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Abstract 
 
Nowadays, cardiovascular diseases are reported as a major cause of death and disability in 
developed countries. Therefore, stents have emerged as a solution to overcome this problem. 
However, common commercialize stents, are metallic, which present several disadvantages as 
corrosion, higher risk of restenosis and infection. In order to minimize the disadvantages associated 
with these stents, new materials, like fibrous materials, have begun to be used as well as surface 
modifications of biomaterials begun to be applied, in order to avoid those drawbacks, especially 
infection. Therefore, the main objective of this work was the development of a fibrous stent, able 
to compete with the mechanical properties of the commercial ones, with the advantaged of being 
coated with an antibacterial agent, able to avoid infections. 
For this purpose, braided stents were produced by varying materials, structural and process 
parameters, such as monofilament type and diameter, braiding angle and mandrel diameter. The 
influence of these design parameters on mechanical behavior, as well as stent's porosity, was 
thoroughly investigated, and suitable parameters were selected for developing a stent with 
mechanical characteristics and porosity matching with the commercial stents. According to the 
experimental results, suitable performance was achieved with a polyester stent designed with: 
monofilament diameter of 270 µm, braiding angle of 35°; and mandrel diameter of 6 mm, 
providing similar properties to commercial Nitinol stents (porosity above 70%, unchanged diameter 
during bending tests above 75%, force for longitudinal compression between [0.16-5.28] N and 
force for radial compression between [1.13-2.90] N).  
After the stent’s development, silver and silver oxide thin films were deposited by non-reactive and 
reactive pulsed dc magnetron sputtering. The coatings were characterized chemical, physical and 
structurally. This first approach in stent’s functionalization revealed that silver thin film formed a 
continuous layer, while silver oxide layer was composed of islands with hundreds of nanometers 
surrounded by small nanoparticles with tens of nanometers. In order to verify the antibacterial 
behavior of the coatings, halo inhibition zone tests were realized for Staphylococcus epidermidis 
and Staphylococcus aureus. Silver coatings did not show antibacterial behavior, contrarily to silver 
oxide coatings, which presented antibacterial properties against the studied bacteria. The presence 
of silver oxide phase along with the development of different morphology were pointed as the main 
factors in the origin of the antibacterial effect found in silver oxide thin film.   
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With the purpose of understand the influence of oxygen species in the physical, chemical and 
structural properties of thin films new silver and silver oxide thin films were deposited, by non-
reactive and reactive pulsed dc magnetron sputtering, with the variation of oxygen content. The 
resulted coatings revealed that silver coating forms a continuous layer. The incorporation of oxygen 
leads to the formation of a mixture of Ag2O + AgO phases. However, with the increase of the oxygen 
fraction, the mixture of oxides disappear and the resultant thin film became only AgO.  
Cytotoxicity tests were performed, demonstrating that in the silver oxide coating no cytotoxicity was 
found, making this coating able to be used in stents applications. 
The antibacterial behavior of coatings was, quantitatively, tested against Staphylococcus epidermis, 
showing that AgxO unlike Ag coating presented antibacterial behavior. The presence of silver oxide 
is the main reason for the antibacterial effect, probably due to the increased production of reactive 
oxygen species (ROS). 
Finally, and in order to evaluate the coating’s behavior when subjected to mechanical forces, coated 
silver and silver oxide stents were, again, mechanically tested, and no loss of adhesion or 
delamination were observed, indicating that coatings will support, adequately, the mechanical 
forces and the dangerous of delivering parts of coating in blood current will not occur. 
In conclusion, fibrous stents coated with silver oxide, present a good mechanical behavior, when 
compared with nitinol commercial stents, possess antibacterial properties and are no cytotoxic, 
which made this stent a promising candidate as a biomaterial and a viable substitute to metallic 
stents. 
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Resumo 
 
Atualmente, as doenças cardiovasculares são consideradas a principal causa de morte e 
incapacidade nos países desenvolvidos. Os stents surgiram como uma solução para este 
problema, contudo, os que se encontram no mercado são metálicos, pelo que apresentam várias 
desvantagens como: corrosão, maior risco de reestenose e infeção. A fim de minimizar as 
desvantagens associadas a estes stents, novos materiais, como materiais fibrosos, começaram a 
ser utilizados, assim como, a modificação da superfície dos biomateriais, de forma a evitar a 
infeção. Consequentemente, o principal objetivo deste trabalho foi o desenvolvimento de um stent 
fibroso, capaz de competir com as propriedades mecânicas dos stents comerciais, com a 
vantagem de ser revestido com um agente antibacteriano, evitando, deste modo, a possibilidade 
de infeção. 
Para este efeito, foram produzidos diferentes stents entrançados, através da variação dos 
materiais, parâmetros estruturais e de processo, tais como: o tipo de monofilamento e o seu 
diâmetro, ângulo de entrançamento e diâmetro do mandril. A influência destes parâmetros no 
comportamento mecânico, bem como a porosidade dos stents foram estudadas detalhadamente. 
Para o desenvolvimento do stent foram selecionados os parâmetros adequados com o objetivo de 
obter caraterísticas mecânicas e porosidade compatíveis com os stents comerciais. De acordo 
com os resultados experimentais, a melhor performance foi obtida com um stent de poliéster com 
diâmetro de monofilamento de 270 µm, ângulo de entrançamento de 35° e o diâmetro do mandril 
de 6 mm, proporcionando propriedades semelhantes ao stents comerciais de nitinol (porosidade 
acima de70%, diâmetro inalterado durante os testes de dobragem acima de 75%, força de 
compressão longitudinal compreendida entre [0.16-5.28] N e força de compressão radial 
compreendida entre [1.13-2.90] N). 
Após a produção do stent, foram depositados filmes finos de prata e óxidos de prata, através da 
pulverização catódica pulsada em magnetrão, em regime não-reativo e reativo. 
Os revestimentos foram caracterizados química, física e estruturalmente. Esta primeira abordagem 
na funcionalização do stent revelou que o revestimento de prata formou um filme contínuo, 
enquanto o filme de óxido de prata era composto de ilhas, com centenas de nanómetros rodeadas 
por nanopartículas com dezenas de nanómetros. A fim de verificar o comportamento 
antibacteriano dos revestimentos, foram realizados testes de halo para Staphylococcus 
epidermidis e Staphylococcus aureus. Como resultado, o revestimento de prata não apresentou 
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comportamento antibacteriano, ao contrário do revestimento de óxido de prata, que apresentou 
propriedades antibacterianas contra as bactérias estudadas. A presença da fase de óxido de prata 
juntamente com o desenvolvimento de morfologias diferentes foram apontados como os principais 
fatores na origem do efeito antibacteriano encontrado no revestimento de óxido de prata. 
Com o propósito de compreender a influência das espécies de oxigênio nas propriedades físicas, 
químicas e estruturais dos filmes finos, foram depositados novos revestimentos de prata e óxido 
de prata, por pulverização catódica em magnetrão, em regime não-reativo e reativo, com variação 
do teor de oxigénio. Os revestimentos resultantes revelaram que os revestimentos de prata 
formaram uma camada contínua. A incorporação do oxigénio levou à formação de uma mistura 
de fases de Ag2O + AgO. Contudo, com o aumento da fração de oxigénio, a mistura de óxidos 
desapareceu e os filmes finos resultantes apresentaram apenas a fase de AgO. 
Foram realizados ensaios de citotoxicidade, demonstrando que o revestimento de óxido de prata 
escolhido não é tóxico, tornando-o adequado para ser aplicado em stents. 
O comportamento antibacteriano dos revestimentos foi, quantitativamente, testado contra 
Staphylococcus epidermis, revelando que os revestimentos de AgxO, ao contrário dos 
revestimentos de Ag, apresentam um comportamento antibacteriano. A presença do óxido de prata 
é um dos principais fatores para o efeito antibacteriano, provavelmente, devido ao aumento da 
produção de espécies reativas de oxigénio (ROS). 
Finalmente, e de modo a avaliar o comportamento do revestimento quando submetido a forças 
mecânicas, os stents revestidos com prata e óxido de prata foram, novamente, testados 
mecanicamente, e não se observou perda de adesão ou a delaminação do filme. Estes resultados 
indicam que os revestimentos conseguem suportar, de forma adequada, as forças mecânicas e 
que não haverá risco de perda de revestimento para a corrente sanguínea. 
Em conclusão, os stents fibrosos revestidos com óxido de prata, apresentam um bom 
comportamento mecânico, quando comparado com os stents comerciais de nitinol, além de 
apresentarem propriedades antibacterianas e não serem citotóxicos, o que torna este stent um 
candidato promissor como substituto para os stents metálicos atuais. 
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NaCl Sodium chloride 
NP Nanoparticle 
P Radial Pressure 
PA Polyamide 
PBS Phosphate Buffer Saline 
PBMA Poly(nbutyl methacrylate) 
PDLA Poly (D-lactic acid)  
PE Polyethylene 
PES Polyester 
PET Polyethylene terephthalate 
PEVA Poly(ethylene-co-vinyl acetate) 
PLD Pulsed Laser Deposition 
PLGA Poly(lactic-co-glycolic acid) 
PLLA Poly(L-lactic acid) 
pO2,in Input oxygen partial pressure 
PP Polypropylene 
PS Penincilin Steptomycin 
PTFE Polytetrafluoroethylene 
PVD Physical Vapour Deposition 
QACs Quaternary Ammonium Compounds  
R Mandrel Radius 
Rf Radio Frequency 
ROS Reactive Oxygen Species 
SAMs Self-assembled Monolayers  
SE Secondary Electron 
SEEY Secondary electron Emission Yield 
SEM Scanning Electron Microscopy 
SIBS Poly(styreneb-isobutylene-b-styrene) 
SS 316L 316L Stainless Steel 
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T Time taken by the horn gear to make one revolution 
Τ Mean Size of the Ordered (Crystalline) Domains 
TSA Tryptic Soy Agar 
TSB Tryptic Soy Broth 
V Take up speed 
XPS X-ray Photon Spectroscopy 
XRD X-ray Diffraction 
 Angular Speed of Bobbins 
 Take out Speed 
Wh Angular velocity of the horn gears around their own centers 
Wy Monofilament width 
ƳlTot Surface Free Energy 
ƳlLW Apolar Lifshitz-van der Waals Surface Free Energy Component 
Ƴl+ Electron Acceptor Surface Free Energy Component 
Ƴl- Electron Donor Surface Free Energy Component 
Z1, Z2, Z3 Number of Teeth of gear wheel 1, 2 and 3, respectively; 
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Scope of the thesis 
 
Metallic stents, commonly used nowadays, have several disadvantages, such as corrosion, 
infection and restenosis, leading to health complications for the patient, or even to his death. 
Although there are different kinds of stents, like pharmacological stents, that can deliver drugs, 
there is not an “ideal” stent being able to overcome the disadvantages of commercial ones.    
Thereby, the main purpose of this work is to develop a multifunctional fibrous stent, able to 
eliminate corrosion and minimize the disadvantages of metallic stents, increasing the useful life of 
the stent and well-being of the patient. 
In addition, the innovation of the present study is the incorporation of silver and silver oxide 
nanocoatings, on the stent’s surface, so that silver can be released, providing an antibacterial effect 
and thus, preventing infections. The developed coating should not be cytotoxic, once it will be in 
contact with human body and no harm should be observed, as well as the delamination of the 
coating should not be observed.    
The innovative stent will be different from the available stents, because there is no 100% fibrous 
stent, with mechanical performance similar to metallic ones, with a coated surface, that provides 
an antibacterial behavior.  
Therefore, the main motivation of this research work is to develop a fibrous based stent (and, this 
way, eliminate the corrosion problem) and understand the behavior of silver-based coatings on the 
antibacterial properties of stents and solve the disadvantages associated with current stents. 
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Structure of the Thesis 
 
This thesis is divided in six chapters.  
Chapter I concerns a general introduction about stents and the main problems associated to 
them. Due to the need to continue studying and developing new materials and techniques to avoid 
the major problems of current stents, fibrous materials have begun to be used. Although the 
innovation in materials reduces and eliminates some problems, like corrosion, infection is an 
important issue that need to be controlled. Thus, an explanation about possible functionalization 
techniques and antibacterial agents is added in this chapter.  
Globally, this first chapter describes the disadvantages of metallic stents, currently available in the 
market, and explain how to reduce their utilization through the use of fibrous materials, associated 
with functionalization techniques, in order to provide antibacterial properties to stents.  
Chapter II encloses the production and mechanical characterization of fibrous stents, outlining 
the fundamentals about the methodologies, as well as the influence of production technique 
parameters in final mechanical behavior. Taking in account all the mechanical tests performed, 
and after the comparison between the results for fibrous stents with the results of nitinol stents, 
described in literature, the fibrous stent with the best performance was chosen. This stent is in the 
further research experiments related to the functionalization with antibacterial properties.  
Chapter III describes silver and silver oxide coatings production by non-reactive and reactive 
pulsed dc magnetron sputtering, respectively. These coatings were produced in order to evaluate 
if they can be suitable candidates to functionalize the fibrous stent and provide it antibacterial 
behavior. Thus, silver and silver oxide coatings were chemical, morphological and physical 
characterized. 
With the study presented in this chapter it was possible to observe that silver oxide coating was a 
potential coating with antibacterial properties, however, the main reason for that behavior was not 
clear. So, the influence of the oxygen in the antibacterial properties should be studied. 
Chapter IV presents the production of silver and silver oxide coatings, by non-reactive and reactive 
pulsed dc magnetron sputtering, with the variation of the oxygen content, in order to understand 
the influence of oxygen in the coating’s properties, which was not clear in previous chapter.   
In Chapter V, and after study and chose the best coatings in Chapter IV, the fibrous stent 
produced in Chapter II was functionalized with silver and silver oxide coatings. The result stents 
were biological characterized, where, cytotoxicity and antibacterial performance was evaluated in 
 xxvi 
 
further detail. Additionally, and in order to evaluate the coating’s behavior when subjected to 
mechanical forces, coated stents were, again, mechanically tested. 
Finally, in Chapter VI, the major conclusions of this thesis are presented and future work is 
suggested.  
Figure 1 shows a diagram representing the different stages of this research project, which will be 
described, along the thesis. 
 
 
 
Figure 1-Schematic representation of the different stages of the thesis.
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1. Introduction 
 
Metallic stents used nowadays, have several disadvantages, like corrosion, low radiopacity, 
restenosis and can cause infection. Thus, it is important to study new materials, in order to 
eliminate or minimize those disadvantages and proportionate a long durability to stents and a better 
well-being to the patient. 
  
1.1. Coronary diseases 
 
Cardiovascular diseases (CVD) are a tremendous problem for public health, since they are a major 
cause of death among Europeans and worldwide in both sexes, and have high health care costs. 
The Global Burden of Disease study estimated that in 2010 CVD caused more deaths than all 
communicable, maternal, neonatal and nutritional disorders combined, and double the number of 
deaths caused by cancers, reaching 15616.1 million deaths, corresponding to 29.6% of all deaths 
worldwide [1]. 
Coronary heart disease, namely, atherosclerosis of the coronary arteries is one of the most principal 
CVD and manifests itself when there is clustering of cholesterol (fat produced by the body) in the 
arterial walls, obstructing blood flow. Additionally, the accumulated cholesterol can cause a clot, 
leading to severe circulatory problems [2]. In Table 1 is represented the number and correspondent 
percentage of deaths from CVD and, in particular, coronary hearth diseases in Europe, in the last 
available year (2014).  
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Table 1-Number and percentage of deaths from cardiovascular diseases and coronary heart diseases in Europe (adapted 
from:[1])  
 Cardiovascular 
Diseases (total) 
Coronary Heart 
Diseases 
Males  
Total deaths 1 862 774 42% 876 017 20% 
Deaths before age 75 939 698 36% 473 501 18% 
Deaths before age 65 508 132 31% 253 432 16% 
Females  
Total deaths 2 219 326 51% 903 330 21% 
Deaths before age 75 536 712 37% 232 683 16% 
Deaths before age 65 201 492 27% 77 166 10% 
Total  
Total deaths 4 082 100 46% 1 779 347 20% 
Deaths before age 75 1 476 410 37% 706 184 18% 
Deaths before age 65 709 624 30% 330 598 14% 
 
Arteries are blood vessels, whose main functions are myocardial irrigation and oxygen and nutrients 
transportation, carrying blood from the heart to all parts of the body. These vessels are composed 
by different layers (Figure 2). The outer layer is composed of connective tissue, the intermediate 
layer is based in smooth muscle tissue and elastic tissue and the inner layer is comprised of 
endothelial cells.  Atherosclerosis occurs when there is a damage in the innermost layer of arterial 
tissue [2].   
 
 
Figure 2- Schematic representation of an artery. 
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Atherosclerosis of the coronary arteries can be treated by drugs, such as anticoagulants or 
antiplatelet agents, or by surgical procedures. Initially, this disease was treated by coronary 
angioplasty [3], which is a surgical procedure, whose goal is the extension of the coronary arteries, 
to restore normal blood flow. In this procedure, a catheter, which has a small balloon at its end, is 
inserted at patient’s blocked artery. The balloon catheter is positioned at the obstruction and it is 
inflated, in order to cause a dilation of the artery [4]. However, although angioplasty is a very 
innovative technique, it has some disadvantages, including high rates of restenosis or reocclusion 
of arteries [5]. Thus, stents have emerged as a mean of solution to this problem (Figure 3). 
 
 
Figure 3- Conventional angioplasty (a)) and angioplasty with stent (b)) 
(image adapted from:[2]). 
 
1.2. Stents 
 
Stents are rigid and perforated tubular structures, which are inserted into blood vessels (Figure 3b) 
in order to prevent or inhibit the constriction of blood flow, restoring the normal blood flow, when 
blood vessels are clogged, and are nowadays used in 70% of angioplasties [2,6]. The use of 
cardiovascular stents has become one of the most important achievements of the last century in 
the area of surgical cardiology in heart diseases [7].  Cardiovascular stents were first used in 1986 
in Toulouse, France, but its approval by the FDA (Food and Drug Administration) only occurred in 
1994. First coronary stents used were bare-metal.  Since then, stents have been evolved, in terms 
of implantation mechanism, materials, methods of manufacture and coatings. These devices can 
be divided into conventional or pharmacologic stents. The first ones are endovascular fasteners, 
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typically in metal (Figure 4), whose function is to maintain dilated artery. Pharmacologic stents 
belong to the second generation of stents and are available commercially since 2002. These stents 
are also metallic stents; however, they have the incorporation of drugs [2].  
 
 
Figure 4- Conventional metallic stent (image adapted from:[8]). 
 
Nevertheless, although pharmacologic stents reduced rates of restenosis, when compared with 
balloon angioplasty, restenosis continued to develop in 20% - 30% of lesions. Even though stent 
insertion stabilizes vascular dissections and prevents arterial recoil, restenosis still occur because 
of physiological processes that induce the cells’ growth in stents, leading to arterial reclusion. In 
addition to act as a vascular scaffold, stents soon evolved to become drug delivery systems in the 
form of Drug Eluting Stents (DES). These devices aim to minimize vascular inflammation and 
cellular proliferation, which leads to restenosis [9]. 
Despite the first generation of DES had be considered revolutionary, by today’s standards they are 
rudimentary. First DES were comprised by a metallic stent, usually stainless steel,  coated with a 
polymer that elutes drugs as antiproliferative or anti-inflammatory agents [9].   There are two drug-
eluting stents approved by FDA: poly(ethylene-co-vinyl acetate) (PEVA) and poly(nbutyl 
methacrylate) (PBMA), and poly(styreneb-isobutylene-b-styrene) (SIBS). The first one is made of 
316L stainless steel and coated with a mixture of PEVA and PBMA, which contains sirolimus, to 
combat restenosis. In order to control drug release, a drug-free top coat of PBMA is applied. The 
second one is, equally, made of 316L stainless steel, but it is coated with SIBS mixed with paclitaxel 
[10]. Besides the good results showed by these stents, polymer coatings may lead to thrombosis 
and, in this way, polymer-free coatings/surfaces appeared. This approach uses nanoporous and 
microporous surface stents, as well as nanoparticles on stents surface [11]. Although nanoparticles 
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have been extensively studied and applied as drug delivery system, the results of stent surface 
coated with them have few reports [12]. 
Sousa et al. [13] compared the performance between conventional and pharmacological stents 
(sirolimus coated stent), and their study showed that the use of pharmacological stents leads to a 
reduction of, approximately, 80% of restenosis. Table 2 presents the advantages and disadvantages 
associated to both types of stents. 
 
Table 2- Advantages and disadvantages of conventional and pharmacological stents (adapted from [2]) 
Stents Advantages Disadvantages 
Conventional 
Low price, 
Reduced chance of late clots 
forming. 
 
Higher rates of restenosis; 
Induction of trauma during 
deployment; 
Corrosion and the consequent 
release of ions to the body. 
Pharmacological Lower rates of restenosis. 
 
Delay healing and increase 
endothelial inflammation; 
Higher rates of thrombosis; 
Price. 
 
Stents must possess certain requirements, in order to, adequately, perform its function, such as 
biocompatibility (so that its use does not cause damage on the health of its user), longitudinal 
mechanical strength ([0.16-5.28] N), radiopacity (so that it is easy to see), longitudinal flexibility, 
ease of handling, corrosion resistance and having high  radial strength ([1.13-2.9] N) and ability to 
recover [2,14].  
 
1.3. Metallic Stents 
 
Stents can be made of different materials, but metals, particularly stainless steel, are the most 
common, due to its high tensile strength and corrosion resistance. However, metallic stents have 
low radiopacity. There are, also, some metal alloys used in stents production, such as cobalt 
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chromium alloy, once they are radiopaque and biocompatible with high radial strength, and nickel-
titanium, or nitinol [2]. 
Nitinol is a nickel and titanium alloy, which has properties suitable for stent applications, such as: 
shape memory properties, which enables this material to be easily compressed, but when in 
contact with blood flow it reacquires the size, i.e., it assumes the original shape after exposure to 
body temperature; high elasticity and resistance to fracture [15–17]. Moreover, although the 
human body is a very complex electrochemical system, which provides extremely aggressive and 
corrosive environment, nitinol implants show no signs of corrosion. This advantage is due to the 
fact that when inserted into human body, the implant is covered with a thin layer of oxide, which 
reacts with titanium to form titanium oxide that stabilizes the surface and prevent the reaction 
between the medium and nickel ions [18,19]. Although there are some researches testing nitinol 
biocompatibility and showing that no significant negative effects are found in nitinol implants, it is 
theoretically possible that nickel may dissolve from the material and cause adverse effects [20].  
In Table 3, a comparison between main mechanical properties of nitinol and stainless steel is 
presented. 
 
Table 3- Properties of nitinol and stainless steel (adapted from: [21]) 
 Strength Stiffness Fatigue 
Corrosion 
Resistance 
Stainless Steel 300-560 MPa 200 GPa 
Good in load 
control 
Good- Cr2O3 
 
Nitinol 500- 1400 MPa 25 - 80 GPa 
Good in strain 
control 
Excellent- TiO2 
 
 
Nevertheless, the use of most metallic stents presents some disadvantages, such as: corrosion, 
restenosis and bleeding complications. Restenosis occurs in approximately 30% of patients in the 
period of 9 months after the procedure and it is associated with a high mortality rate, as well as 
the costs of health care [2]. One of the main factors associated with restenosis is the damage of 
the arteries caused by stents metal rods, which causes an immune and inflammatory response by 
the body [6]. With the intention of minimize the disadvantages of metallic stents, some studies 
were carried out, namely to improve high-strength and radiopacity, and minimize metal ion release 
and restenosis [22]. One of the most important properties of stents is their thickness, once this 
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characteristic affects the ability of track the stent through the blood vessel and then cross through 
lesions. Stents with thinner struts are more flexible, reduce cross section profiles and, 
hypothetically, reduce restenosis rates [23,24]. Despite the effect of thickness in restenosis, the 
long-term effect leads to developments to higher-strength materials, able to be design with 
reduction in strut thickness. Thus, the introduction of cobalt-chromium alloys that have the 
advantage of having a good corrosion resistance, in stents production began to be studied and 
developed. In Table 4 are summarized some coronary stents that use this trend of reducing 
thickness by the use of higher-strength materials and composite structures [22]. 
 
Table 4- Correlation of typical yield strength values with strut thickness for some stents 
Stent name/ manufacturer Material 
0.2% Yield 
strength (MPa) 
Strut 
thickness (µm) 
BX Velocity®/Johnson & Johnson 316L 340 140 
Express®/Boston scientific 316L 340 132 
Driver®/Medtronic CoCr MP35N 415 91 
VisionTM/Abbott CoCr L605 510 81 
TriMaxxTM/ Abbott 316L/Ta/316L Not applicable 74 
 
Furthermore, biocompatibility issues have been increasing attention, once it was believed that the 
increase in surface biocompatibility could reduce restenosis rate for bare metal stents below the 
typical levels of 20% - 30%.  Regardless of the effort and novel approaches, these coatings seems 
not to play a significant result in the restenosis reduction, in their existing configuration, as 
demonstrated in Table 5.  
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Table 5- Summary of clinical trial data with inorganic coated stents 
Study description Restenosis rates 
DLC vs stainless steel [25] 
31.8% for Diamond Flex AS stent 
35.9% for bare Flex AS stent 
DLC vs stainless steel [26] 
24.3% for PhytisTM Diamond 
21.8% for PentaTM stainless steel 
Ion-implanted carbon vs. stainless steel [27] 
11.0% for ArthosInert carbon implanted stent 
16.1% for Arthos stainless steel stent (NS) 
TenaxTM SiC vs.NIR 316L [28] 
30.0% for SiC-coated stainless steel stent 
26.7% for NIRTM stainless steel stent 
TiNOX trial [29] 
15.0% for titanium-nitride-oxide 
coated stent 
33.0% for same design stainless steel stent 
 
In order to minimize the drawbacks associated with metallic stents, new materials, like fibrous 
materials, have begun to be used. As the surface of fibrous materials can be easily functionalized 
to enhance their compatibility with human tissues, they present high potential for application in 
stents [30]. 
 
1.4. Fibrous Stents 
 
Fibrous materials used in medical applications include: fibers, yarn (monofilament or 
multifilament), textile structures (braided, knitted, woven and non-woven) and composites. These 
materials, applied in medicine, can be natural or synthetic, biodegradable or non-biodegradable. 
Currently, there are fibrous stents or stents with fibrous components: stents  with fibrous structure 
combined with metals, stents coated with polytetrafluoroethylene (PTFE), polyester (PES) stents, 
polyamide (PA) stents, polyethylene (PE) stents, PTFE stents  and poly (L-lactic acid) (PLLA) stents 
[2,22]. 
The idea of using implantable fibrous structures is not new and the use of these materials in stents 
have been studied, because they eliminate the problem of corrosion and can minimize the 
occurrence of restenosis associated with metallic stents. Furthermore, the use of monofilaments 
has a high potential for stents development because, in addition to being biocompatible, these 
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materials allow the application of various surface treatments, such as drug delivery [2,30]. 
Furthermore, monofilament exhibit excellent mechanical properties, like greater stiffness and good 
results when subject to compression, tensile and bending forces, since these forces will be directly 
borne by the yarn [31]. 
Freitas et al. [31] developed polypropylene stents through two distinct methods: knitting and 
braiding technologies. Better results were obtained for braided structures, such as dimensional 
stability, mechanical strength and high recovery of the original shape, and concluded that this 
technique is the most suitable for stents development.  
Braiding technique consists in the interlacing of two or more thread systems, in the diagonal 
directions, forming an integrated structure. This method is an advantage, since it provides greater 
visibility of the stent, flexibility and rate of collection up to 87% of the stent on the device, in addition 
to be a simple process, versatile and provide a high level of compliance, torsional stability and wear 
resistance [6]. 
The use of polypropylene monofilaments showed some advantages, such as low cost, high stiffness 
and resistance to rupture. However, stents were not sufficiently flexible for blood vessel contours. 
Further studies were carried out in order to find the ideal fibrous material for stents and other 
implantable devices. França and Pereira [6] showed that the polyester fiber is the most commonly 
used for vascular grafts because of its biocompatibility and availability in the market, besides being 
an inert, flexible and resilient material. On the other hand, Avino et al. [32] evaluated the placement 
of nitinol stents coated with polyester in dog’s aortas, and concluded that although there is an 
increased proliferation of cells in the stent surface, the lumen area was not changed. Furthermore, 
Marty et al. [33] found that polyester stent, when inserted in smaller vessels; induced a cellular 
response that can lead to thrombosis. 
More recently, hybrid braided stents of polyamide and nitinol were developed, showing excellent 
dimensional stability and mechanical performance and the use of based nitinol stents exhibit a 
shortening in less than 3%  [2,6]. Thereby, it was found that the braiding technique is very efficient 
and the stent performance is, directly, related to the braiding angle [2]. 
Some of natural based stents were also studied and they are already marketable. Tamai et al. [34] 
used PLLA stents in human applications (Igaki-Tamai stent). This stent presents a thickness of 
0.17 mm and a zigzag helical coil pattern, and was implanted in 15 patients. During 30 days no 
thrombosis or major cardiac events were observed, and follow-ups with angiography and 
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intravascular ultrasounds were realized 1 day, 3 months and 6 months after stent implementation. 
No major cardiac event, except for repeated angioplasty, developed within 6 months [34]. 
Nishio et al. [35] evaluated the long-term safety of the Igaki-Tamai stent over 10 years, where 50 
patients with 63 lesions were treated electively with Igaki-Tamai stents. Generally, clinical follow-up 
for cardiac events and rates of scaffold thrombosis was analyzed with the results of angiography 
and intravascular ultrasound. At the end of the study, authors conclude that the rate of major 
cardiac events were similar to those of metallic stents, and no stent recoil was observed, suggesting 
a long-term safety of Igaki-Tamai stent [35]. 
Absorb® (VHL) is a fully bioresorbable stent made of PLLA, coated with poly (D-lactic acid) (PDLA) 
that uses the everolimus drug, and it was approved in 2011 for use in Europe. The second 
generation of this stent (BVS 1.1) uses PLLA, as well, however, has some modifications in polymer 
processing and scaffold design that leads to a higher radial strength and mechanical integrity 
[36,37]. 
Despite the promising results for biodegradable stents these structures have a lower radial force 
when compared with metallic and should be compensated for thicker structures [36]. 
 
1.4.1. Methods of stent’s production 
 
Fibrous stents may be produced using woven, knitting and braiding technologies. The woven type, 
in addition to provide a low elasticity, tends to wrinkle and fold easily, with high difficulties in 
assuming the sinuous contours of the blood vessels [6]. Braiding technique is the most suitable 
technique for stent development as the produced structures exhibit good dimensional stability, 
mechanical strength, high shape recovery and flexibility [6]. Moreover, braiding technique is a 
simple and versatile process, providing the structures high compliance level and torsional stability 
[6]. Braided structures have been well studied for application in medical implantable devices like 
sutures, artificial ligaments, etc [38,39]. A few studies have demonstrated the possibility of using 
braided structures for producing self-expanding stents. For example, Zhao et al. [40] fabricated 
braided stents using shape memory Nitinol wires. The developed braided stents, however, showed 
lower radial strength as compared to the welded stents, owing to relative sliding of Nitinol wires 
within the braided structures and therefore, found less effective to restore the patency of the 
stenotic artery. Further studies on Nitinol braided stents revealed that due to the slippage between 
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the wires and superelastic behavior of Nitinol, they showed a hysteresis between loading and 
unloading cycles under the compressive tests [41]. 
Braiding angle was observed to be the main design parameter deciding the mechanical 
performance of Nitinol braided stents. Braided stents have also been fabricated using shape 
memory polymers such as polyurethane and their mechanical performance has been characterized 
and simulated using finite element analysis [42]. It was observed that the design parameters like 
fiber diameter and braiding angle can be carefully selected to match the performance of 
polyurethane stents to that of metallic stents. However, shape memory polyurethane shows viscous 
phenomena such as stress relaxation and creep, which should be minimized. Also, due to much 
inferior mechanical properties of this polymer to Nitinol, it should be used as thicker fibers, reducing 
blood flow through the vessels. The strong influence of number of filaments and stent diameter on 
the mechanical performance of stents was also noticed in the case of braided stents produced with 
polyester fibers [42]. 
The possibility of producing bioabsorbable braided stents has been explored using PLLA fibers [38] 
and the produced stents showed similar radial pressure stiffness to metallic stents and maintained, 
at least, half of their radial pressure stiffness for more than 22 weeks. These initial research studies 
on braided stents investigated separately the influence of some of the design parameters on 
selected properties of stents such as radial compression. 
 
1.4.1.1. Braiding technique 
 
Braided fibrous structures result from the interlacing of two or more systems of yarns in the 
diagonal directions, forming an integrated structure. This type of processing is simple and versatile 
and differs from woven and knits in the method of insertion of the wires and the way the threads 
are interlaced [43,44]. Production of braided structure is relatively simple and no complex yarn 
preparation process is required. Therefore, this technique is one of the most cost - effective textile 
manufacturing processes.  Additionally, braiding technique can work even with the most difficult 
and least flexible yarns once yarn’s path in braiding structure is simple and straight [45].    
Braiding machines are used for the production of braided structures, which can be vertical or 
horizontal, depending on the take out direction of the structure, and can produce 2D or 3D 
structures. Circular braiding process is used to produce hollow and circular shapes. A circular 
braiding machine is composed by a circular platform where carriers are placed, to hold the spools 
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of yarn. The number of spools can be controlled and depends on the desired density of yarn in the 
final braided structure. A mandrel, which, usually, is a solid and removable component, can be 
added during the production in order to provide the final shape and give longitudinal reinforcement. 
The shape and thickness of the mandrel is another parameter that can be controlled.  The yarns 
are held together, during the braiding process, in the mandrel’s surface, forming a braided self-
supported structure [45]. Two of the most important controlled parameters are the rotation speed 
of carriers and mandrel’s take out velocity.  In Figure 5 is represented a typical braided structure.   
 
 
Figure 5- Braided structure. 
 
Braiding axis consists in the direction of braiding formation. Line can be described as one repeat 
of braiding structure perpendicular to braiding axis while stich is one repeat of braiding structure 
along the braid axis. Regarding braiding angle, it is the most important parameter of braiding 
process and it determines the mechanical performance of braiding structure [45]. This parameter 
depends on the number of braiding yarns and the take up speed. The braiding angle (α) represents 
the angle between the monofilaments and the longitudinal axis of braided structure (Figure 5).  
Braiding angle can be calculated using equation (1) [14,46]: 
 
 𝛼 = tan−1(
𝜔𝑅
𝑉
) (1) 
 
where, 
α= braiding angle (rad); 
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angular speed of bobbins (rad/s); 
R= mandrel radius (cm); 
v= take up speed (cm/s). 
 
Angular velocity () and angle made by horn gears can be calculated using the following equations: 
 
𝜔 =
𝜃
𝑇
 
(2) 
 
where, 
θ= angle made by a pair of adjacent horn gears at the machine center (rad); 
𝑇 = time taken by the horn gear to make one revolution (s). 
 
𝜃 =
2𝜋
(
𝑁ℎ
2 )
=
4𝜋
𝑁ℎ
 
(3) 
 
𝑇 =
2𝜋
𝑁ℎ
 
(4) 
 
𝜔 =
2𝜔ℎ
𝑁ℎ
 
(5) 
 
Therefore,  
 
𝛼 = tan−1(
2𝜔ℎ𝑅
𝑁ℎ𝑉
) 
(6) 
 
Take out velocity can be controlled varying the teeth of gear wheels in a braiding machine, as 
observed in Figure 6. 
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Figure 6- Scheme of work of braiding machine, with four gear wheels. 
(Z1 - 1st gear wheel, Z2 – 2nd gear wheel, Z3- 3rd gear wheel and Z4- 4th gear wheel) 
 
A braiding machine works with four gear wheels that can be varied, increasing or decreasing the 
take out speed. The first gear wheel receives the rotation caused by the motor and gives it for the 
others gear wheels. This gear wheel is in contact with the reduction zone which comprises two 
gear wheels on the same axis. These two are in contact with the last gear wheel, which provides 
rotation to the axis of the calender. Varying the position and the teeth of gear wheel is possible to 
control the take out speed, through equation 7 [2].  
 
𝜔2 =
𝑍3
46
∗
𝑍1
𝑍2
∗ 𝜔 (7) 
 
Where, 
Z1, Z2, Z3= number of teeth of gear wheel 1, 2 and 3, respectively; 
= angular speed of bobbins (rpm); 
2= take out speed (rpm). 
 
2. Infection 
 
Despite the innovation on stents, its use also has some disadvantages, namely bacterial infection. 
Usually, this infection results in prolonged hospitalization and, therefore, a higher cost associated 
with medical services, and in extreme cases, death of the patient [6]. 
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After stent implantation, proteins, from the blood or tissue, directly adsorb onto the surface. The 
layer formed by adsorbed proteins has a very important role in bacterial adhesion [47,48]. The 
free swimming bacteria, in the so - called planktonic state, will in vivo adsorb to this surface coated 
with proteins (Figure 7 (A)). These bacteria will proliferate and recruit another bacterium from the 
neighbor environment (Figure 7 (B)), forming a colony in surface, and change their gene expression 
pattern (Figure 7 (C)). This gene modification will be responsible for the production of extracellular 
polymeric substances, which are essential in the formation of biofilm along with nucleic acids and 
other substances (Figure 7 (D)).  [49]. The biofilm slowly grows and small parts of it can break off 
and planktonic bacteria escape from the biofilm and can invade new, clean surfaces at distant sites 
(Figure 7 (E)).  
Thus, a biofilm is an accumulation of microorganisms embedded in a matrix of polysaccharides 
difficult to eradicate. Biofilms are medically important, since they are responsible for over 80% of 
microbial infections in the body, and they may be form on biological or non-biological surfaces [50]. 
 
 
Figure 7- Biofilm formation (image adapted from [49]). 
 
Therefore, the stent surface characteristics, such as, hydrophobicity, roughness, porosity and 
chemical composition, have a direct influence in proteins adsorption and, consequently, in a biofilm 
formation and infection.  
Even though coronary artery stent infections are associated with a high mortality rate only few 
cases of stents infection have been reported, however the percentage of hospital infection, in 
Portugal is 10.6%, a value that is above the European prevalence, which is 6.1% [51,52]. 
Nevertheless, infection of medical devices can arise due to several reasons and from different 
sources; some of the most common sources of infection are: contaminated device surfaces, hands 
of medical staff and patients own skin or mucus membrane, among others. Many of these risk 
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factors can be easily avoided, but, infections are impossible to evade completely [53]. The infection 
of these devices is due to the colonization caused by gram-positive or gram-negative bacteria or 
yeasts [54,55]. Gram-positive Staphylococcus species, like Staphylococcus epidermis and 
Staphylococcus aureus are reported as the major isolated species from medical devices [54,56].  
Staphylococcus epidermis is a gram-positive, coagulase-negative Staphylococcus (it does not 
produce the enzyme coagulase responsible by the blood plasma coagulation) that is a part of our 
normal flora and colonizes the skin and mucous membranes of the human body [57–59]. This 
bacterium is characterized for about 1 µm round cells, and it can be found in single cells, in pairs 
or in clusters [60]. Another bacterium associated with coronary diseases is Staphylococcus aureus, 
which is a gram-positive bacterium that can be found in the human respiratory tract and skin 
[61,62]. 
One way to prevent infection is trough surface modification of the implantable device, in such a 
way that no bacterial adhesion can occur. Characteristics like, hydrophobicity, roughness and 
chemical composition have an important influence on bacterial adhesion.  Overall, higher 
hydrophobicity provokes greater bacterial adhesion [57,63].  
Thus, in order to minimize the reaction of the human body and fight the adhesion of 
microorganisms to stent surface, some stent coatings have been developed, including: PTFE, 
polyethylene terephthalate (PET), polyurethane, carbon films and the incorporation of anti-
thrombotic, anti-proliferative and antimicrobial agents, as well as incorporation and delivery of 
antibiotics and the use of novel metals and other compounds with antimicrobial properties [6,49]. 
 
3. Functionalization of stents 
 
In order to minimize the limitations of available stents, many studies have tried to solve these 
problems by stent modification. With modification or coating of the stent’s surface, it is intended 
to improve the stent’s biocompatibility, modifying their surfaces with less thrombogenic and 
inflammatory materials, reducing the infection and the occurrence of thrombosis and restenosis, 
by coating the stent with therapeutic agents, which are released, over time, after stent implantation 
[64]. 
The main methods of coating include layer by layer (LBL) technique, thiol chemistry, chemical 
vapor deposition (CVD*) and physical vapor deposition (PVD) methods.  
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3.1. Antibacterial Coatings 
 
There are, mainly, three different types of stent’s coating: biocompatible coatings, drug-delivery 
coatings and polymer-free coatings/surfaces [11]. 
Biocompatible coatings comprehend, mostly, inorganic materials, like silver, gold or carbon. These 
coatings have as main function, to increase the stent biocompatibility and to serve as a barrier to 
ion release by metallic stents. Usually, biocompatible coatings have no capacity to carry drugs. To 
avoid this disadvantage, biocompatible polymer coatings were developed, which can release 
therapeutic agents. These coatings can be nonbiodegradable polymers or biodegradable polymers 
like: poly(lactic acid) (PLA), poly(glycolic acid) and their copolymer, poly(lactic-co-glycolic acid) 
(PLGA).  As previously mentioned, there are two drug-eluting stents approved by FDA:  PEVA and 
PBMA. Even though the good results showed by these stents, polymer coatings may lead to 
thrombosis and, in this way, polymer-free coatings/surfaces appeared. [11,65]. 
Following, it will be described some therapeutic agents (antibiotics, quaternary ammonium 
compounds and silver based agents) with antimicrobial properties, which can be used, as coatings, 
in order to minimize infection and adverse reactions in the human body. 
The use of antibiotics has increased considerably after the discovery of penicillin and they can be 
divided in two different types: bactericidal, when cell death is induced, or bacteriostatic, if just cell 
growth is inhibited. Antibiotics can inhibit deoxyribonucleic acid (DNA) synthesis, bacterial protein 
synthesis or bacterial cell walls synthesis [66]. Although the use of antibiotics is associated with 
implanted medical devices, it shows some disadvantages.  Antibiotics, normally, cannot reach the 
bacteria, since it is quite difficult for them to penetrate the formed biofilm in the implanted devices. 
Therefore, the concentration of antibiotics presented in the biofilm becomes very low, and this led 
to the development of bacteria´s resistance to antibiotics [12,67].  
To increase the effectiveness of antibiotics, they can be applied locally on the implant surface, 
because bacteria are then killed directly before the biofilm formation. Some biodegradable coatings 
containing antibiotics can be used [64]. In that case, antibiotics are released at the time when 
these coatings get degraded. This approach is not viable for long term implants, once the 
concentration of antibiotics is finite. Therefore, after some time, the implantable device is again 
subjected to biofilm formation and consequent infection [12]. Furthermore, there is a serious 
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concerning by World Health Organization with the use of antibiotics and the antibiotic resistance 
caused, and consequently, the advertising of the reducing use of antibiotics [68]. 
Quaternary ammonium compounds (QACs) are used as antimicrobial agents and are very popular 
since it is very easy to manufacture these compounds in large scale as well as to modify their 
surface area. These compounds are used as antimicrobial compounds since 1935 and can be 
used as disinfectants also. The antibacterial effect showed by QACs can be explained by two 
different mechanisms. In the first one, the presence of positive charge on a surface can release 
cations to the bacteria wall, and in this way, break the external membrane of bacterium. In the 
second suggested mechanism, the cationic surface can change its configuration and, in this way, 
lead to the bacteria’s lysis. In respect to the mechanism, the presence of a positive charge on 
QACs has a negative effect on cell survival in general [69,70]. On the other hand, when QACs are 
in contact with bacteria they will reduce their viability and cells will die. Moreover, QACs can cause 
antimicrobial resistance, which decrease their efficiency. Thus, the application of QACs is still very 
limited as antimicrobial surface coatings for medical implants [49]. 
The use of novel metals, as for example silver, is one of the most used strategies to prevent the 
adhesion of microorganisms to medical implantable devices. Silver has been used for centuries as 
an antimicrobial agent. From the medical point of view, silver was used by ancient Egyptians, 
Greeks and Romans to clean wounds. The use of silver in medical applications has grown until 
1940, when penicillin was introduced for infection treatment. However, in 1968, silver nitrate was 
combined with sulphonamide to form silver sulfadazine (AgSD).  This compound became the best 
known use of silver as an antibacterial agent and for treatment of burns. AgSD is like a reservoir of 
silver that slowly releases silver ions, causing membrane bacterial damage [71].  
Despite silver being a well-known antimicrobial agent and having a broad-spectrum of activity, its 
mechanism of action is not fully understood [72,73]. However, it is suggested that the antimicrobial 
behavior of silver can be achieved by: i) the release of Ag+ ions, ii) the interaction of bacteria with 
silver nanoparticles and iii) the formation of reactive oxygen species (ROS) [53,57,61,74]. 
In metallic state, silver is inert but it reacts with moisture and fluids from the wounds and gets 
ionized. In the case of silver ions, the antimicrobial properties are due to structural and 
morphological changes. Silver ions can penetrate inside the bacterial cells impeding the DNA 
replication and, consequently, leading to the cell lysis. Moreover, silver ions have a far lower 
propensity than classic antibiotics to induce antimicrobial resistance [75]. 
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Besides the antibacterial properties exhibited by silver, it can be toxic to organisms after a 
prolonged contact with silver ions [22]. Despite all medical applications of silver and silver ions, 
the information about its toxicity is limited. However, some studies demonstrated that some forms 
of silver, especially silver ions (Ag+), are more toxic than other forms [49]. 
The toxicity of silver can be observed in the form of argyria, which is an irreversible disease that 
discolours the skin.  The ophthalmologic system can also suffer from prolonged exposure to silver 
resulting in a condition called argyosis [49,71,75]. 
Among all strategies for providing antimicrobial properties to implantable devices, like stents, the 
use of silver is one of the most common and effective techniques, nevertheless when silver is 
directly incorporated into implantable devices’ surface can be released very quickly, limiting the 
time period of antibacterial protection [49,76–78].  Furthermore, metallic silver cannot provide 
enough antimicrobial activity and deteriorate fast [49,71,79] and the addition of silver salts into 
surface coatings is not a good solution because of the poor solubility of most silver salts [49]. 
Thus, the need arises for the incorporation of silver nanoparticles (NP) which may coat the 
implantable device surface and, dependent on the way the NP are fixed to the surface, increase 
the time period of silver’s antimicrobial activity [31]. 
Silver nanoparticles can reduce colonization, infection rate, hospitalization days, and present 
economic benefits and are more efficient in antimicrobial aspects than silver salts due to their 
enormously large surface area, which provide better contact with the microorganisms [49]. In 
metallic state, silver interacts with thiol groups present in the bacterial cells and inhibits the 
respiratory process, leading to the cell death.  In some specific bacterium, such as Escherichia 
coli, the antimicrobial effect is provided by the inhibition of the uptake of phosphate and release of 
phosphate, mannitol, succinate, proline and glutamine [71]. 
As mentioned previously, the mechanism of antibacterial action of silver is not absolutely clear. 
The silver nanoparticle’s efficacy depends on the size and shape of particles. Small silver particles 
(< 10 nm) and triangular shaped particles demonstrate higher antibacterial activity as compared 
to big and spherical particles. Small silver nanoparticles produce electronic effects through the 
interaction with bacteria, and this intensifies the reactivity of nanoparticles [80]. According to Seil 
et al. [81], triangular shaped nanoparticles are a better option since they need less amount of silver 
to show bacterial inhibition. While triangular nanoparticles need 1 µg of silver, the spherical 
nanoparticles need 12.5 µg and rod shaped nanoparticles need 50 to 100 µg [71]. Silver 
nanoparticles activity against common bacteria, like Staphylococcus aureus, have been 
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investigated and a concentration of 50 µg.mL-1 was reported as the need concentration to cause 
the death of bacteria [82,83]. Stents and other implantable medical devices with silver 
nanoparticles incorporated on a matrix on their surface slowly release silver ions into the matrix 
and, subsequently, into the solution. When in contact with bacteria and chemical compounds of 
their metabolism, the Ag dissolution increases and, consequently, bacterial inhibition is more 
effective.  
The concentration of silver ions required for optimal antibacterial effect is observed between 10 
nM and 10 µM [49]. 
Nakato et al. [84] deposited NP’s on metallic stents surface and drug release kinetics was 
evaluated and they conclude that NP - eluting stent is a potential innovative method.  
Several synthesis techniques were developed to obtain silver nanoparticles with different shapes 
and sizes, such as laser ablation, gamma irradiation, electron irradiation, chemical reduction by 
inorganic and organic agents, photochemical methods, microwave processing and thermal 
decomposition of silver oxalate in water and in ethylene glycol. The efficiency of antimicrobial 
properties is also dependent on synthesis technique. 
Regarding the formation of ROS, they can be generated inside or outside the cell and are 
byproducts of respiring organisms’ metabolism. Induction of ROS formation leads to the synthesis 
of highly reactive radicals that can cause the mitochondrial damage of the microorganism, 
accelerating the cell death or dysfunction. It is reported that silver can generate ROS, potentially 
including superoxide (O2•-), hydroxyl radicals (•OH.), singlet oxygen (1O2) and the most stable ROS 
(H2O2) [85]. Therefore, it should be also possible to improve silver antimicrobial characteristics by 
forming reactive oxygen species, which leads to a most effective antibacterial behavior of silver, 
due to the toxic character of these species to bacterial cells. For example, Ferreri et al. [72] used 
oxidized nano-silver to achieve antibacterial behavior.  
Silver oxides systems have not been well studied, since silver is, generally, consider as a non-
reactive material [86]. The Ag-O system presents several defined compounds, such as Ag2O, Ag3O4, 
AgO and Ag4O3, being the Ag2O and AgO the most stable at high oxygen pressure and low 
temperature [87–89]. Regarding their synthesis, the most popular method is evaporation of 
metallic silver following by an oxidation, in a reactive environment (normally, a reactive plasma 
excited by dc (direct current) magnetron or microwave), or sputtering [86]. 
The different mechanisms of silver actuation are summarized in Table 6 . 
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Table 6-Summary and schematic representation of mechanisms of silver antibacterial action 
Silver ions can penetrate inside 
bacteria and induce morphological 
and structural damage, promoting 
their lysis, by the inhibition of DNA 
replication. 
 
Silver nanoparticles (NP’s) 
interact directly with bacteria, and 
are claimed to be more effective, 
once present a high surface to 
volume ratio, tending to be more 
easily ionized. 
 
ROS lead to the synthesis of highly 
reactive radicals that can cause the 
mitochondrial damage, accelerating 
the cell death or dysfunction. 
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In last few years the applications of silver nanoparticles and nanocoatings in medicine field have 
been rising [80].  
 
3.2. Functionalization techniques 
 
Generally, silver nanoparticles and nanocoatings are deposited, impregnated or coated onto 
medical devices for controlling infections. With the advance of nanotechnology, new techniques are 
used to coat the medical devices with thin layers of silver. 
Impregnation is one of the oldest and simple methods of incorporating antimicrobial agents into 
textile fabrics. For example, it has been used for application of silver nanoparticles on to cotton 
fabrics. This technique is extremely simple and can be used in clinical situations, since it only 
requires AgNO3, butylamine and absolute ethanol. The antimicrobial activity is controlled by the 
concentration of reactants used. Impregnation can be applied in fibrous materials. For example, 
dried cotton fabrics have cellulosic walls containing OH- groups on the surface of cotton. Therefore, 
cotton can be functionalized through its immersion in the solution described above. The bonding 
with OH groups will reduce silver and provide an antimicrobial activity [90]. 
However, using the impregnation technique, the rate of the deposition of nanoparticles on the 
substrates is low and nanoparticles can be released due to weakness of interactions between 
nanoparticles and fibers [91]. 
Layer by layer is another technique of functionalization that was introduced in 1991 and since then 
it became one of the most popular techniques for preparation of nanoscale films with tailored 
properties. The principle of layer by layer technique is based on the alternating adsorption of 
materials containing complementary charged or functional groups to form integrated thin films. 
Normally, this technique begins with the adsorption of a species having opposite charge of the 
substrate and this reverses the charge of the substrate. This process is repeated forming several 
layers, until the desired thickness is achieved, as demonstrated in Figure 8 [92–94]. 
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Figure 8-Layer-by-layer technique (figure adapted from [92]). 
 
The film properties can be controlled by varying the type of species adsorbed, the number, and, 
consequently, the thickness of layers and the conditions employed during the assembly process. 
The great advantage of this technique is that it allows a variety of materials, such as polymers, 
nanoparticles, proteins, among others; to be assembled on different substrates and the attachment 
can be through electrostatic interactions but also through hydrogen bonding, hydrophobic 
interactions, covalent bonding, and complementary base pairing [92]. 
This technique has been studied and employed on stents [95], by deposition of a thin film. For 
example, LBL assembly on nitinol surfaces facilitates the incorporation of nitric oxide donor and, 
this way, the bacterial adhesion is reduced [96].  
Mahapatro et al. [97] used self-assembled monolayers (SAMs) to incorporate and deliver 
therapeutic drugs (prednisolone as model drug) from stent surface into human body. SAMs are 
ordered nanosized molecular coatings, which add 1 to 10 nm thickness to a surface. The study 
showed that monolayers with a few monometers thick can preserve the chemical groups on the 
surface and can persist on surface of stainless steel stents for 14 to 21 days, before oxidation and 
desorption of the thin film. 
In the last few years, the deposition of metallic nanoparticles, onto polymeric substrates is being 
practiced increasingly due to their strong antimicrobial activity [91]. In order to modify surface 
properties or to fabricate self- assembled monolayers, the adsorption of thiol molecules, especially 
on noble metals, like silver and gold, are being studied. The adsorption of thiol occurs in several 
steps, starting with physical adsorption, then sulfur-metal bonding reaction, followed by the 
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orientation of adsorbed molecules and, finally, the formation of a compact self –assembled layer 
[98]. 
One of the most widely used techniques for the functionalization of biomaterials is PVD. This 
technique is used in stents, due to its ability of deposition of a thin film onto non-uniform geometry. 
PVD provides strongly adherent films and optimal adhesion and integrity upon stent expansion 
[99]. PVD comprises a number of deposition techniques all of which allow transport of materials 
in the solid state between the target and the substrate (the material to be coated), through 
evaporation or sputtering, forming a thin film, due to nucleation and coalescence. This process 
begins with the nucleation of small clusters, which grows and coalesces, forming a thin film on 
substrate surface [96]. 
This entire process must occur under vacuum, to prevent material contamination, and to increase 
the distance between collisions among atoms, allowing the majority of atoms leaving the material 
to migrate to the substrate surface [100]. 
In the sputtering technique, the target is bombarded with very energetic ions gas (with previous 
plasma formation) which will lead to the ejection of particles of target material to be transported 
and deposited on the substrate. Ejected particles are, essential, atoms in fundamental state and 
ions [101]. Sputtering yield depends on the mean number of ejected atoms from target by incident 
particle, allowing quantification of technique’s efficiency. This parameter depends on several 
factors as: energy of the incident particles, type of target, incidence angle, and type of incident 
particle (mass and reactivity) [101]. Reactive gases can be used, in order to obtain a reactive 
atmosphere. In this case, the sputtering process is denominated reactive sputtering and 
interactions between sputtered atoms and reactive gases occurs in target and substrate surfaces 
[102]. 
Sputtering presents some advantages such as: i) sputtering target provides a stable and extended 
lifetime source; ii) it is possible to use reactive gases, such as nitrogen, oxygen and acetylene and 
iii) it is an ecological process. In this technique there are different configurations like magnetron, 
radio frequency or pulsed source sputtering. The magnetron sputtering is used in 90% of PVD 
techniques [103]. 
Magnetron sputtering uses a magnetic field, along with a direct current (dc) or radio frequency (rf) 
source, formed by the introduction of magnets, which is placed in parallel to the target and 
perpendicularly to the electric field, causing an increased flow of electrons around the target (Figure 
9). The magnetic field induces a circular movement in electrons, and, in this way, increases the 
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probability of collision between electrons and ions of the gas, typically argon. With the increase of 
ion density, due to the increased number of collisions between the electrons and gas atoms, the 
deposition rate increases, due to the higher sputtering yield [101,104]. 
 
 
Figure 9- Schematic representation of the magnetron. 
 
The major disadvantage of this process lies in the fact that only 20-30% of the target material is 
used, as observed in Figure 10 .  
 
 
Figure 10- Example of a target used in magnetron sputtering. 
 
In contrast, the magnetron sputtering allows controlling effectively the deposition parameters and 
the quality of coatings and reduces the impurities in the film [101,103]. 
Reactive magnetron sputtering occurs when a gas is introduced in deposition chamber with the 
intuit of making part of the final film, allowing the formation of complex compounds from a simple 
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metallic target, as for example, the formation of silver oxides, through the introduction of oxygen in 
the deposition chamber. The main disadvantage of this process is its complexity, due to the 
unpredictability of where the reactions can occur: in the substrate, during the atoms transportation 
or in the target. If the reactions take place in the target, it is poisoned and sputtering yield 
decreases, as well as the deposition rate [101]. 
Diamond-like carbon films (DLC films) for cardiovascular implants have successfully been prepared 
by dual-target unbalanced magnetron sputtering and Rapid Photothermal Processing, achieving a 
biocompatible coating of a Ti/DLC nanolayers, suitable for medical implants [105]. 
Furthermore, PTFE and 316L stainless steel, as potential materials to be applied in stents, have 
been co-deposited by radiofrequency magnetron sputtering to produce a gradient surface coating 
that progresses from a metal base to PTFE at the surface [106]. 
More recently, Elmrabet et al. [107] used PVD magnetron sputtering to coat minitubes with 
magnesium for Mg - biodegradable stent applications. As main conclusions, authors referred 
magnesium minitubes as a candidate system for a biodegradable stent with a good corrosion 
resistance in phosphate buffer saline (PBS). 
 
Taking in account all the improvement and developments in materials, design and production of 
stents, and antibacterial agents and functionalization techniques, it is extremely important to 
compromise all the factors in order to produce a new stent. This stent should have good mechanical 
and antibacterial properties but, at the same time, with a biomaterial behavior, i.e., with no adverse 
reaction with human body. Thus, the main innovation of this work was the development of a 100% 
fibrous stent, able to compete with the mechanical properties of those available in the market, with 
the advantaged of being coated, through magnetron sputtering, with a silver-based antibacterial 
agent, able to avoid infections and, this way, minimize the advantages of currently used stents.  
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1. Introduction 
 
According to studies conducted over the applicability of fibrous materials on medicine, polyamide, 
polyester and polypropylene fibers appear to be the most suitable for implantable devices [2,30]. 
Polypropylene fibers were slowly inserted in the market, not only due to economic reasons, but 
also technical. The main technical reasons for this delay were the material's sensitivity to heat, 
limitations of dyeing and requirements of the manufacture process. Currently, polypropylene is 
used in steam sterilization because it presents a high melting point, 170 °C, low moisture 
absorption and high impact strength [108]. 
Polyester is a synthetic thermoplastic fiber widely used, i.e., deformable with heat, but not with 
cooling. The most important commercial polyester fiber is obtained through polyethylene 
terephthalate (PET). Polyester is widely used in fibrous prosthetic, being relatively inert, flexible and 
resilient, resistant to wear and tear and can be sterilized by all methods [109]. This fiber has also 
high mechanical strength and high dimensional stability, as well as biocompatibility [2,108]. 
The main polyamide fibers used are polyamide 6 and polyamide 6.6. Polyamide 6.6. was the first 
to appear in the world market, produced by DuPont®, while the polyamide 6 appeared only about 
two years later. Polyamides (polyamide 6 and polyamide 6.6) have a high capacity to absorb 
moisture, are resistant to very low temperatures, have high term oxidative stability, have high 
mechanical strength and abrasion resistance and are resistant to organic solvents and 
hydrocarbons [108]. Table 7 shows the main properties of the fibers to be used in this research. 
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Table 7- Properties of fibrous materials 
Fibers Characteristics 
Polypropylene 
Steam sterilization, low moisture absorption, 
good impact resistance. 
Polyester 
Good mechanical strength, good dimensional 
stability, inert, flexible, resilient, it can be 
sterilized by all methods. 
Polyamides 
High moisture absorption capacity, resistance 
to very low temperatures, high mechanical 
strength, high term oxidative stability, high 
abrasion resistance, resistance to organic 
solvents and hydrocarbons. 
 
Fibrous stents may be produced using woven, knitting and braiding technologies, being the braiding 
technology the most suitable.  
Research studies on braided stents investigated separately the influence of some of the design 
parameters on selected properties of stents. However, effective designing of braided stents should 
consider the influence of all important design factors related to material (such as fiber type and 
diameter), structure (such as braiding angle) and process (mandrel diameter) on the required 
characteristics such as porosity and cover factor, radial and axial compression, bending behavior, 
etc. As no existing study investigated all these factors together, a systematic investigation is highly 
essential to study and understand all these factors and properties, in order to produce suitable 
fibrous stents for replacing commercial metallic stents. To address this, the present study 
investigates the influence of different design parameters such as monofilament type and diameter, 
braiding angle, and mandrel diameter on the porosity and various mechanical properties 
(longitudinal and radial compression and bending properties) of braided fibrous stents and suitable 
parameters have been selected to design fibrous stents with characteristics matching with the 
commercial Nitinol stents.1 
 
                                                          
1 The production and mechanical characterization of fibrous stents, corresponding to this chapter of the work, was developed in partnership with 
other researcher from Fibernamics group, at University of Minho. 
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2. Materials and Methods 
 
2.1. Characterization of raw materials  
 
Polyester (PES), polyamide 6.6 (PA) and polypropylene (PP) monofilaments were used to produce 
braided stents. Linear density, mechanical and friction properties of these monofilaments with 
three different diameters were evaluated. For the determination of monofilament breaking force 
and elongation at break, ISO2062 standard [110] was used. Linear density was measured following 
NP2060 standard [111] while friction coefficient was evaluated using the method described in 
ASTM 3108 [112] which reports the procedure for friction coefficient measures between fibers and 
solid materials. The result of the measurement assumes a value between 0 and 1. 
 
2.2. Braiding Conditions 
 
In order to produce the braided stents, a vertical braiding machine (Trenz Export 16/100), shown 
in Figure 11, with 16 yarn bobbins, was used. All stents were produced using 16 filaments. Stents 
with different characteristics were produced by varying the monofilament type (polyester, 
polyamide and polypropylene) and diameter (300 µm, 400 µm and 500 µm for PA; 270 µm, 350 
µm and 550 µm for PES and 260 µm, 300 µm and 370 µm for PP), mandrel diameter (3.2, 5 
and 6 mm) and braiding angle (20°, 30° and 35°). These combinations of braiding angles were 
accomplished taken in account previously calculation, using equation 1.  
 
  
Figure 11- Vertical braided machine used in the development of stents. 
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After production, stents were thermofixed in order to maintain the integrity of the braided structure. 
The temperature of thermofixation for each type of fiber was set after differential scanning 
calorimetry (DSC) analysis. DSC is a thermal analysis which allows the measuring of material’s 
physical properties as function of time and temperature. DSC is used to measure melting point 
temperature, heat of fusion, latent heat of melting, reaction energy and temperature, glass 
transition temperature, crystalline phase transition temperature and energy, among other 
properties [113].  
 
2.3. Cover Factor and Porosity Evaluations  
 
The amount of fibrous materials deposited on the mandrel surface during the braiding process 
depends on the braiding process parameters and it can be estimated using cover factor. Cover 
factor is defined as the percentage of mandrel surface covered by monofilaments. This is a good 
indicator of braid’s structural uniformity [46]. Porosity is another important parameter for stents 
and should range between 70 and 80% [41]. Cover factor and porosity were calculated using 
equation 8 and equation 9, respectively. 
 
𝐶𝑜𝑣𝑒𝑟𝐹𝑎𝑐𝑡𝑜𝑟 = 1 − (1 −
𝑊𝑌𝑛𝑐
4𝜋𝑅 cos 𝛼
)
2
                                                                                (8) 
Where, 
Wy=monofilament diameter (mm); 
nc= number of bobbins; 
R= mandrel radius (mm); 
α= braiding angle (rad). 
 
𝑃𝑜𝑟𝑜𝑠𝑖𝑡𝑦 = 1 − 𝐶𝑜𝑣𝑒𝑟 𝐹𝑎𝑐𝑡𝑜𝑟                                                                                          (9)
 
2.4. Measurement of Radial Compression  
 
It is highly essential to characterize the radial compression, as stents with insufficient radial force 
can lead to revision surgeries. When a radial pressure is applied, stents undergo a structural 
deformation leading to an expansion in the longitudinal direction and shrinkage in the transversal 
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direction (Figure 12). This deformation results in change of stent diameter and braiding angle 
[114].  
 
 
Figure 12- Scheme of resultant axial force in a stent when subjected to radial pressure. 
 
Due to radial compression, stents decrease in diameter and increase in length. Therefore, the 
relationship between the length (Lf) of a single filament per turn and the stent diameter (D) 
becomes: 
 
𝐿𝑓 =
𝜋𝐷
sin 𝛼
 (10) 
𝐷 = 𝐷𝑎
sin 𝛼
sin 𝛼0
                                                                                                         (11) 
 
Where: 
D= new average stent diameter (mm); 
Da= average stent diameter (mm); 
α0= Initial braiding angle (rad); 
α= new braiding angle (rad). 
 
The extension in the total length of stent (∆ℎ) can be obtained by equation 12. 
 
∆ℎ =
𝜋𝐷𝑎
sin 𝛼0
(cos 𝛼 − cos 𝛼0)  (12) 
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For the radial compression test, stents were held between two flat plates in a universal testing 
machine and 15 samples with 8 cm in length were compressed up to 25% of their original diameter, 
as shown in Figure 13. The average force of compression was then calculated.  
 
 
Figure 13– Setup of radial compression test. 
 
Radial and longitudinal compression tests were performed at Laboratório de Física Têxtil da 
Universidade do Minho, in a universal tensile machine (Hounsfield HK100) with a load cell of 50 
N, with a speed of 25 mm.min-1 and a pre-load of 0.01 N. 
 
2.5. Determination of Longitudinal Compression 
 
Stents should have good axial compression resistance; otherwise they will be easily compressed 
at their ends due to a slight trauma while exchanging different catheters [115]. Developed stents 
were compressed to 15% of their original lengths and the required force for this compression was 
measured [116]. For longitudinal compression tests, 15 samples of 8 cm length were compressed 
to 1.2 cm, in a universal testing machine (Figure 14), with the same conditions described for radial 
compression, and the average force was calculated.  
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Figure 14-Setup of longitudinal compression test. 
 
2.6.  Determination of Bending Properties 
 
Bending behavior plays a vital role in deciding the stent performance. After stents are implanted in 
to the human body, they should maintain at least, 75 % of its original diameter, in order to allow 
blood flow and avoid stent collapse. The diameter of a bent stent was measured at the midpoint of 
the bent section of the stent (shown in Figure 15 by arrow) according to the method proposed by 
Kim et al.  [3]. By this method, 3 samples with 8 cm length were bent until their ends were 
separated by 2 cm (Figure 15). The ratio of the stent diameter in the bent condition and the initial 
diameter (expressed in percentage) was obtained and this parameter represents the percentage of 
original diameter which remained unchanged during the bending test. Unchanged diameter can 
be calculated using equation 13. 
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Figure 15- Measurement of unchanged bending diameter. 
 
 
𝑈𝑛𝑐ℎ𝑎𝑛𝑔𝑒𝑑 𝑑𝑖𝑎𝑚𝑒𝑡𝑒𝑟 = (
𝐷𝑏
𝐷𝑖
) ∗ 100 (13) 
 
Where: 
Db= stent diameter in bent condition (mm); 
Di= initial stent diameter (mm). 
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3. Results and Discussion 
 
3.1. Development of braided fibrous stents  
 
The results of fibrous materials characterization (monofilaments) are provided in Table 8. 
 
Table 8- Characterization of raw materials 
  PA   PES   PP  
Diameter 
(µm) 
300 400 500 270 350 550 260 300 370 
Linear 
density 
(Tex) 
73.49 
(0.04) 
126.00 
(0.04) 
214.49 
(0.03) 
82.79 
(0.03) 
133.38 
(0.02) 
341.45 
(0.13) 
67.09 
(0.03) 
71.10 
(0.02) 
101.30 
(0.02) 
Tensile 
strength 
(N) 
40.52 
(0.66) 
72.20 
(1.56) 
107.80 
(4.45) 
39.07 
(1.11)* 
58.30 
(1.26) 
142.66 
(1.93) 
28.86 
(0.33) 
43.65 
(2.02) 
47.74 
(0.32) 
Initial 
Modulus 
(N/Tex) 
2.03 
(0.11) 
1.75 
(0.14) 
1.72 
(0.15) 
5.79 
(0.12) 
1.10 
(0.03) 
4.65 
(0.09) 
2.57 
(0.06) 
5.51 
(0.10) 
2.88 
(0.18) 
Tenacity 
(N/Tex) 
0.56 
(0.01) 
0.57 
(0.01) 
0.50 
(0.02) 
0.47 
(0.01) 
0.44 
(0.01) 
0.42 
(0.01) 
0.43 
(0.01) 
0.61 
(0.03) 
0.47 
(0.01) 
Elongation 
(%) 
30.48 
(2.36) 
30.01 
(1.67) 
30.59 
(4.20) 
16.15 
(1.58) 
33.44 
(1.64) 
19.07 
(1.29) 
27.36 
(5.76) 
15.24 
(1.31) 
21.12 
(1.13) 
Friction 
coefficient 
0.35-
0.45 
0.3-0.35 0.3-0.4 0.40-0.45 0.40-0.45 0.25-0.3 0.15-0.20 0.25-0.3 
0.12-
0.15 
Density 
(g/cm3) 
1.14 1.38   0.9 
*The values within the brackets are S.D. 
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According to the type of fiber, stents were thermofixed at different temperatures. Along with the 
results of DSC, presented in Figure 16, Figure 17 and Figure 18 it is possible to observe that the 
melting point of PES, PA and PP is around 257.8 ⁰C, 221.2 ⁰C and 138.5 ⁰C, respectively. Thus, 
polyester and polyamide stents were thermofixed at 182 ⁰C and 186 ⁰C during 1h, respectively. 
Regarding polypropylene, stents were thermofixed at 130 ⁰C, during 10 min. These results are in 
agreement with those reported in literature [2,31].  
 
 
 
Figure 16-DSC analysis for PES fibers 
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Figure 17- DSC analysis for PA fibers. 
 
 
Figure 18-DSC analysis for PP fibers. 
 
For easier understanding, samples were coded according to material type, monofilament diameter, 
braiding angle and mandrel’s diameter, as shown in Table 9, Table 10 and Table 11. Thus, the 
sample code PES270A20D32 corresponds to a polyester sample with 270 µm monofilament 
diameter, braiding angle of 20° and mandrel diameter of 3.2 mm. 
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Table 9- Coding and producing parameters of samples for PES fiber  
Sample Code Fiber 
Diameter of 
monofilament (µm) 
Braiding angle 
(⁰) 
Diameter of 
mandrel 
(mm) 
PES270A20D32 
PES 
270 
20 3.2 
PES270A30D32 30 3.2 
PES270A35D32 35 3.2 
PES270A35D5 35 5 
PES270A35D6 35 6 
PES350A20D32 
350 
20 3.2 
PES350A30D32 30 3.2 
PES350A35D32 35 3.2 
PES350A35D5 35 5 
PES350A35D6 35 6 
PES550A20D32 
550 
20 3.2 
PES550A30D32 30 3.2 
PES550A35D32 35 3.2 
PES550A35D5 35 5 
PES550A35D6 35 6 
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Table 10-Coding and producing parameters of samples for PA fiber 
Sample Code Fiber 
Diameter of 
monofilament (µm) 
Braiding angle 
(⁰) 
Diameter of 
mandrel 
(mm) 
PA300A20D32 
PA 
300 
20 3.2 
PA300A30D32 30 3.2 
PA300A35D32 35 3.2 
PA300A35D5 35 5 
PA300A35D6 35 6 
PA400A20D32 
400 
20 3.2 
PA400A30D32 30 3.2 
PA400A35D32 35 3.2 
PA400A35D5 35 5 
PA400A35D6 35 6 
PA500A20D32 
500 
20 3.2 
PA500A30D32 30 3.2 
PA500A35D32 35 3.2 
PA500A35D5 35 5 
PA500A35D6 35 6 
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Table 11-Coding and producing parameters of samples for PP fiber 
Sample Code Fiber 
Diameter of 
monofilament (µm) 
Braiding angle 
(⁰) 
Diameter of 
mandrel 
(mm) 
PP260A20D32 
PP 
260 
20 3.2 
PP260A30D32 30 3.2 
PP260A35D32 35 3.2 
PP260A35D5 35 5 
PP260A35D6 35 6 
PP300A20D32 
300 
20 3.2 
PP300A30D32 30 3.2 
PP300A35D32 35 3.2 
PP300A35D5 35 5 
PP300A35D6 35 6 
PP370A20D32 
370 
20 3.2 
PP370A30D32 30 3.2 
PP370A35D32 35 3.2 
PP370A35D5 35 5 
PP370A35D6 35 6 
 
 
3.2. Mechanical behavior of fibrous stents 
 
3.2.1. Cover Factor and Porosity 
3.2.1.1. Influence of fiber type and diameter 
 
Monofilament diameter strongly influences the cover factor and therefore, the stent porosity. As 
per equation 8, for the same production parameters, samples with lower monofilament diameter 
should show a lower cover factor and, consequently, higher porosity. This is attributed to the fact 
that the filaments with lower diameter (i.e. lower width) can cover less area on the mandrel surface 
for a particular mandrel diameter and braiding angle. Consequently, samples with higher 
monofilament diameter should present high cover factor and lower porosity. The influence of 
monofilament diameter and type on stent’s porosity is shown in Figure 19. It can be noticed that 
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the experimental results are in good agreement with equation 8. For all materials, an increase in 
monofilament diameter reduced the porosity due to better cover factors, as observed in Figure 19. 
 
 
Figure 19-Influence of fiber type and diameter on porosity [mandrel diameter: 6mm, braiding angle: 35⁰]. 
 
The influence of material in porosity of produced stents depends mainly on their diameters. Overall, 
due to lower monofilament diameter, polypropylene stents presented lower cover factor and higher 
porosity (reaching maximum porosity of 81%) as compared to polyamide and polyester stents with 
maximum porosity of 78% and 76%, respectively.  
 
3.2.1.2. Influence of mandrel diameter 
 
The influence of mandrel diameter on cover factor of produced stents is shown in Figure 20. It is 
clear that the cover factor decreased with the increase in mandrel diameter. This is in agreement 
with the trend predicted using equation 8. If all other parameters are kept constant, an increase in 
mandrel diameter places less number of yarn coils on the mandrel and thereby reduces the area 
of mandrel covered by yarns. Therefore, an increase in mandrel diameter decreases its cover factor 
and consequently, increases the porosity.  
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Figure 20-Influence of mandrel diameter on cover factor of PA stents (a), PES stents (b) and PP stents (c) [braiding angle: 35⁰]. 
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3.2.1.3. Influence of Braiding Angle 
 
Figure 21 presents the influence of braiding angle on cover factor of produced stents. An increase 
in the braiding angle led to an increase in the cover factor. This trend is also in agreement with 
equation 8. As shown in Figure 21, braiding angle is the angle between the yarn and the longitudinal 
axis of braids and therefore, in increase in the braiding angle leads to deposition of braiding yarns 
more towards the transverse axis. As a result, if a certain length and volume of mandrel is 
considered, higher braiding angle resulted in deposition of higher number of yarn coils and 
therefore, increased the cover factor. Consequently, porosity of the braided stents decreased with 
the increase in braiding angle. 
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Figure 21 - Influence of braiding angle on cover factor of PA stents (a), PES stents (b) and PP stents (c) [mandrel diameter:3.2 
mm]. 
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In Figure 22 it is possible to observe the difference between the stent with lower cover factor 
(PP260A35D6 - 19%) and the stent with higher cover factor (PES550A35D32 - 66%). 
 
 
Figure 22- Difference in PP260A35D6 (a)) and PES550A35D32 (b)) cover factor. 
 
3.2.2. Radial Compression 
 
Theoretically, the radial compression pressure of stents can be expressed as: 
 
𝑃 = −
2𝐹𝑛𝑐
𝐷𝐿
tan 𝛼 (14) 
 
Where, 
P= radial pressure (MPa); 
F= radial force (N); 
nc= number of bobbins; 
D= average stent diameter (mm); 
L= length of stent (mm); 
α= braiding angle (rad). 
 
Therefore, theoretically, radial compression force is dependent on the applied force, number of 
filaments, stent diameter and length as well as braiding angle. 
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3.2.2.1. Influence of fiber type and diameter 
 
The influence of fiber type and diameter on radial compression force is shown in Figure 23. The 
force for radial compression is highly dependent on the monofilament type and their diameter. As 
the diameter of different monofilaments was not the same, it was quite difficult to understand the 
independent effect of monofilament type on radial compression. But overall, polyester stents 
required higher force than polyamide stents and the lowest resistance to radial compression was 
shown by the polypropylene stents. Also, the force for radial compression strongly increased with 
the monofilament diameter. This was attributed to several reasons: (a) higher monofilament 
diameter led to a higher stent wall thickness, resulting in higher radial compression resistance, (b) 
higher monofilament diameter also improved the cover factor, thereby improving the structural 
integrity and compactness of stents and this resulted in higher compression resistance, (c) radial 
compression led to bending and buckling of the monofilaments and therefore, higher bending or 
buckling resistance at higher diameters also increased the force for radial compression. The radial 
compression force for all polyester samples varied between 16.19 N and 1.06 N; for all polyamide 
varied from 15.55N to 0.31N and for all polypropylene varied from 3.66 N to 0.31 N. In case of 
PP stents, the differences observed in radial compression force were very small, as the diameter 
difference was smaller. 
 
 
Figure 23 - Influence of fiber type and monofilament diameter on radial compression force for stents produced with 35° 
braiding angle and 3.2 mm mandrel diameter. 
Chapter II- Production and Mechanical Behavior of Fibrous Stents 
 
 
51 
 
3.2.2.2. Influence of mandrel diameter  
 
The influence of mandrel diameter on radial compression force is presented in  
Figure 24. It can be observed that, except PES550 stent, an increase in mandrel diameter resulted 
in a decrease in the force required for radial compression. As the stents were compressed between 
two flat parallel plates during radial compression, bending and buckling of the monofilaments 
occurred, besides some structural rearrangements which increased the length of stents. An 
increase in mandrel diameter also increased the diameter of stents and the length of the 
monofilaments under the buckling force. Since the buckling force is inversely proportional to the 
length of monofilaments, an increase in mandrel diameter reduced the compression resistance of 
the stents. However, the specimen PES550 did not follow the trend as shown by the other 
specimens. This exception was perhaps due to the higher monofilament diameter with the low 
frictional coefficient of these monofilaments, which could cause monofilament sliding during the 
compression test and therefore, behaved differently from other samples. 
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Figure 24 - Influence of mandrel diameter on radial force of PA stents (a), PES stents (b) and PP stents (c) [braiding angle:35⁰]. 
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3.2.2.3. Influence of braiding angle 
 
The influence of braiding angle on radial compression force is presented in Figure 25. It can be 
noticed that for most of the stents an increase in the initial braiding angle increased the radial 
compression force. This trend is in agreement with equation 14. The primary reason behind this 
was the deposition of yarns more towards the transverse axis of the stents at higher braiding angles, 
leading to more resistance towards transverse forces acting during radial compression. Moreover, 
higher braiding angle also improved the cover factor and compactness of the stent structure 
resulting in higher resistance towards radial forces. However, too high braiding angle may also 
reduce the interlocking of the filaments (as they are arranged more parallel to each other) and 
increase the chance of slippage during compression. As a result, a decrease in the radial force (i.e. 
variation from regular trend) was also observed for some samples at high braiding angles and with 
samples presenting low friction coefficient and high monofilament diameter, such as PES550, 
PA500 and PP300.  
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Figure 25 - Influence of braiding angle on radial compression force of PA stents (a), PES stents (b) and PP stents (c) [mandrel 
diameter:3.2 mm]. 
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As mentioned in Section 3.2.2., radial compression leads to increase in the length of stents and 
this can be calculated using equation 12. After the compression test and relaxation, the stents 
showed some change in the diameter and length, indicating unrecoverable deformation. Table 12 
lists the diameter recovery and longitudinal extension for selected PA and PES samples produced 
with high monofilament diameter and lower mandrel diameter, once these samples shown more 
exceptions in trends presented in section 3.2.2.. PP samples were not analyzed due to the lower 
friction coefficient and similar monofilament diameters, which avoids to correctly study the 
influence of the monofilament diameter. 
It can be noticed that after compression test and relaxation, braiding angles (α) changed to some 
extent from the original ones (α0), indicating structural rearrangement. Some increase in stent’s 
length can also be noticed. Although, stent diameter could not recover completely back to the 
original values, the diameter recovery was more than 80% (Table 12), which is comparable with 
the value obtained with previously reported polypropylene stents [38].  
 
Table 12- Diameter recovery and longitudinal extension of stents after radial compression 
Sample α0 (⁰) α(⁰) 
Da 
(mm) 
D  
(mm) 
Diameter 
recovery (%) 
∆h 
(mm) 
PA500A20D32 35 28.48 4.2 3.49 83.10 1.38 
PA500A30D32 31.02 27.95 4.3 3.82 88.84 0.68 
PA500A35D32 32.64 29.44 4.2 3.83 91.19 0.7 
PES550A20D32 34.29 29.2 4.3 3.72 86.51 1.12 
PES550A30D32 30.35 28.94 4.3 4.12 95.81 0.33 
PES550A35D32 31.84 25.16 4.3 3.47 80.70 1.42 
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3.2.3. Longitudinal Compression 
 
The axial force on tubular stents can be expressed by the following equation [117]. 
 
𝐹 = 2𝑛𝑐 ∗ [
𝐺𝐼𝑝
𝐾3
∗ (
2 sin 𝛼
𝑘3
− 𝑘1) −
𝐸𝐼 tan 𝛼
𝐾3
∗ (
2 cos 𝛼
𝐾3
− 𝐾2)] (15) 
Where: 
𝐾1 =
sin 𝛼0
𝐷0
, 𝑘2 =
2𝑐𝑜𝑠2𝛼0
𝐷0
, 𝐾3 =
𝐷𝑎
cos 𝛼0
; 
 
Where, 
nc= number of bobbins; 
E= Young’s modulus (Pa); 
G= Shear modulus (Pa); 
I= Moment of inertia (kg.m2); 
Ip= Polar moment of inertia (m4) 
α0= Initial braiding angle (rad); 
α= new braiding angle (rad). 
Da= average stent diameter (mm). 
 
It can be noticed from equation 15 that, theoretically, the axial force depends on several parameters 
such as number of yarns, modulus of rigidity and elasticity of braided tubes, moment of inertia of 
the fibers, braiding angle and stent diameter. However, this relationship is quite complex to 
understand the independent effect of each parameter on axial force. 
 
3.2.3.1. Influence of fiber type and diameter 
 
Figure 26 presents the longitudinal compression force for samples with braiding angle of 35° and 
mandrel diameter of 3.2 mm. It can be noticed that PES stents showed higher axial compression 
force as compared to PA stents, which exhibited significantly higher axial compression force than 
PP stents. The higher axial compression resistance of PES stents was attributed to the higher 
modulus of polyester filaments as compared to polyamide filaments. The main reasons for much 
lower axial compression force of PP stents were the lower diameter of PP monofilaments as well 
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as their lower modulus. Stents containing higher diameter monofilaments exhibited higher 
longitudinal compression force due to their higher bending rigidity, as during longitudinal 
compression stents are also subjected to bending and buckling forces. Similar to the case of radial 
compression, PP stents developed with different monofilament diameters presented very small 
difference in longitudinal compression behavior, mainly due to small difference in their diameters.  
 
 
Figure 26 - Influence of fiber type and diameter on longitudinal compression force [braiding angle: 35⁰, mandrel diameter: 3.2 
mm]. 
 
3.2.3.2. Influence of mandrel diameter 
 
The relationship between longitudinal compression force and mandrel diameter can be observed 
in Figure 27. Similar to radial compression, an increase in the mandrel diameter led to a decrease 
in the longitudinal compression force. Higher mandrel diameter resulted in lower cover and inferior 
structural integrity of the stents, resulting in lower resistance towards axial compression force.   
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Figure 27 - Influence of mandrel diameter on longitudinal force of PA stents (a), PES stents (b) and PP stents (c) [braiding angle: 
35⁰]. 
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3.2.3.3. Influence of braiding angle 
 
Figure 28 presents the influence of braiding angle on the longitudinal compression force. An 
increase in longitudinal compression force with braiding angle can be clearly observed for most of 
the stents. This was attributed to the better cover of the stent structures at higher braiding angles, 
resulting in better structural integrity and higher compressive load bearing capability. However, at 
higher braiding angles, yarns became more oriented towards the transverse axis, thereby reducing 
their resistance to axial compression. Due to these two opposing factors, for some of the stents 
there was almost no change in longitudinal compression force with braiding angle. 
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Figure 28 - Influence of braiding angle on longitudinal compressive force of PA stents (a), PES stents (b) and PP stents (c) 
produced using mandrel diameter of 3.2 mm. 
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3.2.4. Bending properties 
 
Bending properties of developed stents were significantly influenced by all studied parameters, 
namely type of fiber, braiding angle, monofilaments diameter and diameter of mandrel and 
therefore, it was too difficult to find independent influence of each of these parameters on bending 
properties. However, for samples of PES and PA with lower monofilament diameters (270 µm, 350 
µm and 300 µm, 400 µm) it was observed that an increase in the braiding angle resulted in better 
bending resistance and higher unchanged diameter. The comparison of bending behavior of 
various stents is presented in Figure 29. It is clear that most of the samples retained more than 
75% of their original diameter during the bending test (indicated by the straight line). 
 
 
Figure 29 - Comparison of unchanged diameter of PA stents (a), PES stents (b) and PP stents (c). 
 
3.3. Discussion 
 
Different requirements have been reported in the literature for obtaining optimal stent design. Most 
of these properties are associated with the mechanical and physical properties of the stent’s 
materials and structures [118]. An ideal stent should have biocompatibility and X-ray and magnetic 
resonance imaging visibility, radial strength, acute and chronic recoil, axial and radial flexibility, 
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deliverability and long term integrity  [118]. Most of the above properties are dependent on each 
other and their careful control is required to obtain an optimal design. For the commercial self-
expandable Nitinol stents, the reported important physical and mechanical properties include radial 
compression, longitudinal compression, bending properties and porosity [116]. Therefore, in order 
to design a fibrous stent that can replace commercial Nitinol stents, the present research attempted 
to investigate important material and structural parameters of braided stents and to select suitable 
parameters to obtain above properties matching with those of Nitinol stents (force for longitudinal 
compression: [0.16-5.28] N and force for radial compression: [1.13- 2.90] N).  
The experimental results presented in the previous sections show that the various properties of 
braided stents are highly dependent on different material and structural factors. Fiber diameter is 
an important material property which significantly influenced all the investigated properties. Higher 
fiber diameter led to higher radial and axial compression resistance, however, at the cost of reduced 
porosity. Similar effect was also observed in case of braiding angle. Higher braiding angle improved 
the mechanical performance, but reduced the porosity. In opposition, the influence of mandrel 
diameter (i.e. stent diameter) was exactly opposite, i.e. higher stent diameter improved the porosity 
and reduced the mechanical performance. The influence of fiber type was primarily associated with 
the fiber’s inherent mechanical properties such as elastic modulus, bending rigidity, etc. Among 
the studied fibers, polyester fiber possesses better mechanical properties and therefore, improved 
the mechanical performance of the stents. Most of the produced stents could maintain more than 
75% of their original diameters during bending test, fulfilling the requirement of commercial Nitinol 
stents. Besides these parameters, fractional properties of fibers also had significant influence. For 
braided stents, fibers should not have very low frictional coefficient as it results in relative sliding 
between the fibers and therefore, results in lower resistance towards axial or radial compression. 
The fibers used in the present study, i.e. polyester, polyamide and polypropylene have been widely 
used in medical applications like sutures [39]. These fibers are suitable for these applications due 
to their good mechanical performance. Biocompatibility of implantable medical devices is also an 
important property and can be strongly influenced by the type of fibers. Overall, the fibers studied 
in this research have good biocompatibility as they lead to low tissue reactions and polypropylene 
is the best fiber in this aspect due to its highly inert nature. 
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3.3.1. Selection of fiber type and design parameters 
 
The main objective of the present study was to develop 100% fibrous stents possessing similar 
physical and mechanical properties as commercial stents. Therefore, suitable design parameters 
have been selected in order to develop stents with properties matching with the commercial Nitinol 
stents. However, according to the requirements of specific applications, completely different set of 
parameters can also be selected. In the present case, samples with higher mandrel diameters (5 
mm and 6 mm) and braiding angle (35°) can be selected to produce the best design. Although 
the increase in mandrel diameter reduced the mechanical performance, it increased the porosity 
and therefore, higher mandrel diameter was found favorable to obtain a good balance between 
mechanical performance and porosity. Similarly, polyester stents were found more advantageous 
due to higher mechanical performance as well as good porosity. Moreover, stents produced with 
lower monofilament diameters can be considered better due to higher porosity with sufficient 
mechanical performance. Considering all these factors, the best specimen produced in this 
research was PES270A35D6, as the properties offered by these stents closely matched with the 
Nitinol stents. Similar approach of selecting design parameters was also followed by Kim et al. [3] 
in case of shape memory polyurethane braided stents and in that case, fiber diameter and braiding 
angle were selected as the design parameters to obtain properties similar to Nitinol stents. 
 
3.3.2.  Comparison with commercial stents 
 
Commercial Nitinol stents were tested elsewhere [116] and their mechanical properties have been 
compared with the selected fibrous stent produced within this study (PES270A35D6). From Table 
13, it is possible to conclude that the developed fibrous stents fulfil the requirements of commercial 
stents, as far as the physical and mechanical properties are concerned and therefore, they can be 
good candidates for practical application. 
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Table 13- Comparison of properties between produced fibrous stents and commercial Nitinol stent 
Properties Nitinol Stent [3,116] PES270A35D6 Stent 
Force for Longitudinal compression [0.16-5.28] N 0.23 N 
Force for Radial compression [1.13-2.90] N 1.29 N 
Porosity >70% 80% 
Unchanged bending diameter >75% 85.5% 
 
4. Partial Conclusion 
 
Within this work, 100% fibrous stents were developed using braiding technology and the influence 
of different materials, process and structural parameters such as fiber type, braiding angle and 
mandrel diameter on their performance was thoroughly investigated. 
According to the experimental results, the best performance (i.e properties closely matched with 
those of commercial metallic stents) was achieved for polyester stents with 270 µm yarn diameter, 
braiding angle of 35⁰ and mandrel diameter of 6 mm, providing the values of radial compression, 
longitudinal compression, porosity and unchanged bending diameter of 1.29 N, 0.23 N, 80% and 
85.5%, respectively. The results obtained in the present study, as summarized in Figure 30, can 
be used to understand different parameters that influence the properties of braided stents and will 
help to design a 100% fibrous stent with targeted set of properties. As the properties of these 100% 
fibrous stents are in the range offered by commercial metallic stents, they have good potential for 
commercial use and this sample will be used for now on in the remaining work.  
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Figure 30- Summary of the production and mechanical behavior of developed fibrous stent. 
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1. Introduction 
 
Despite the great innovations in the development of new stents with improved lifetime, namely the 
use of fibrous materials instead of metal, in order to avoid corrosion, stents, independently of the 
material, still present some disadvantages like bacterial colonization, which leads to the occurrence 
of infections [6]. Thus, in order to prolong the stent lifetime and patient´s safety the development 
of new stent materials with antibacterial properties is of great importance. With the advance of 
technology, new techniques are used to coat the medical devices with thin layers of antibacterial 
agent, such as physical vapor deposition (PVD), one of the most used techniques [91]. One of the 
principal techniques of PVD is sputtering whose purpose is the controlled transport of atoms 
between a target and a substrate on which will take place, at an atomic level, the formation and 
growth of a thin film, which will be the coat [103].  
In this work, a reactive magnetron sputtering equipment, presented in Figure 31, was used to make 
depositions. This equipment is located at Laboratório de Revestimentos Funcionais II, in 
Departamento de Física, at Universidade do Minho.  
 
 
Figure 31- Equipment of reactive magnetron sputtering and a schematic of the interior of the deposition chamber (not at scale). 
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1.1. Silver-based Coatings  
 
In the past years, silver has been studied as an antimicrobial agent [49,119,120]. The antimicrobial 
effect provided by silver depends on the amount of silver and the rate of Ag+ released along time. 
Silver can exist in diverse forms: as metal, as a compound or as a free dissolved ion. The 
antibacterial efficiency of bulk Ag and Ag thin films is quite poor due to the high stability of Ag, 
which turns its ionization and solubility in water very low. In fact, any perfectly formed metallic 
surface in contact with an electrolyte will stabilize quickly; thus if a continuous release of Ag+ ions 
is required, a driving force must exist to provide silver ionization. In order to achieve a continuous 
ion release, researchers have attempted many novel activation processes, such as: thermal, 
mechanical, chemical and electrical stimulation [121–124],still, in a practical point of view the 
application of these external driving forces are quite complex. One adopted approach is the 
incorporation of Ag nanoparticles in different matrix coatings or polymers, which are claimed to 
present an effective bactericidal effect, due to their higher reactivity, promoted by the high surface 
to volume ratio [125]. 
Another approach is demonstrated by Sant et al. [125] that claimed that the presence of 
heterogeneities in Ag based coatings enable to develop bioactive films. In fact, those authors found 
that the presence of fine grain size, incorporation of oxygen species and presence of lattice defects 
allowed to improve the Ag+ dissolution rate, which is attributed to the high energy associated with 
these structural defects.  Furthermore, the incorporation of oxygen species can lead to a higher 
productivity of ROS. These species induce oxidative stress in bacterial cells leading to their proteins, 
lipids and DNA damage and, consequently, the death of bacteria [72,126]. 
Thus, and with the ultimate intuit of functionalize a PES stents with antibacterial activity, stainless 
steel (SS316L) and silicon samples were coated with silver and silver oxide thin films. Silver 
coatings were chosen due to the known antibacterial properties of silver and silver oxide coatings 
were chosen as a way to promote the higher ionization of silver. These substrates were chosen in 
order to easily study and characterize the coating. 
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2. Materials and Methods 
 
2.1. Production of silver and silver oxide coatings 
 
Ag and AgxO coatings were deposited onto 316L stainless steel (20 x 20 mm2) and silicon substrates 
(10 x 10 mm2) by reactive pulsed dc magnetron sputtering. In this stage of the work, polyesters 
stents were only used as substrates, in order to verify the integrity of the stent after the deposition 
process. Once the main objective was the optimization of the coating, SS316L and silicon 
substrates were used to perform the coatings characterization. Before deposition the substrates 
were ultrasonically cleaned with distillate water, ethanol and acetone during 10 minutes in each 
solution. In order to minimize the contamination and remove impurities, before each deposition, 
the silver target and the substrates were etched in an argon atmosphere (Ar flow of 80 sccm) 
during 5 minutes. During the etching process a pulsed dc power supply (MKS, ENI RPG 50) with 
a current of 400 mA and a reverse time and frequency of 1536 ns and 200 kHz, respectively, was 
applied to the substrate holder. Simultaneously, the Ag target was connected to a dc power supply, 
and a current density (JAg) of 0.5 mA.cm-2 was applied.  
Two coatings were deposited: silver coating (Ag) and silver oxide coating (AgxO), with a deposition 
time of 300s and 3600s, respectively.  The coatings were deposited from an Ag target (purity of 
99.99%) with 200 x 100 mm2. During deposition, the sputtering atmosphere consisted in a constant 
argon flow (60 sccm) for both coatings. For oxide coating, a reactive gas (oxygen) was introduced 
with a constant flow of 15 sccm (the maximum flow for the chamber), corresponding to a variation 
in the fraction of oxygen in the discharge [127] (fO2 = 𝝫O2 /(𝝫O2 + 𝝫Ar) to 0.2,  resultant in a 
input oxygen partial pressure (pO2, in=fO2*ptotal) of 1.5*10-1 Pa. The silver coating was deposited with 
the 2.5 mA.cm-2 as current density applied from a pulsed dc power supply to the Ag target.  
Prior to the production of a complete set of samples, some tests were performed varying the current 
applied to the silver target from 2.5 and 1 mA.cm-2. Figure 32 shows the Ag target potential as a 
function of the fraction of oxygen in discharge.  The results demonstrated that only in the case of 
lower current density the poisoning mode could somehow be reached concomitantly, the possibility 
of silver oxides formation is improved.  
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Figure 32 - Variation of target potential as function of fO2 for different applied density currents: a) 2.5 mA.cm--2 and b) 1 mA.cm-2. 
 
 
Thus, for the deposition of the oxide coating 1 mA.cm-2 of current density on the Ag target was 
applied, in order to reach the reactive mode deposition. The reverse time and frequency were kept 
at 1536 ns and 200 kHz, respectively. Samples were placed in a substrate holder that rotated at 
a constant velocity of 7 rpm, 70 mm away from the target. These conditions were chosen based 
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in other studies [128,129] and taking in account that the final purpose is to deposit in fibrous 
materials, and no structural damage should be observed in the substrate. In this sense, the 
depositions were performed without any external heating and no bias polarization was applied on 
the substrate holder. 
 
2.2. Characterization of silver and silver oxide coatings 
 
Stainless steel 316L substrates were used in all characterization techniques that evaluate the 
functional properties, while silicon substrates were used in characterization techniques that 
evaluate the coating´s morphology and structure. Thus, silicon substrates were used in in X-ray 
diffraction (XRD) analysis, once silicon avoids the appearance of substrate’s peaks. In X-ray 
photoelectron spectroscopy (XPS), since silicon’s surface is smoother than stainless steel 316L, 
the analysis is more reliable. 
XPS analysis was performed in order to obtain information about the coatings binding state. This 
technique allows to identify the elements presented in a material’s surface and allows obtaining 
information about their chemical bonds. This information is obtained after the incident of X-rays on 
the material surface (usually with a depth between 0.5 nm and 10 nm), once the X-rays energy 
leads to electron emission from the material surface. The elements are identified through the 
measurement of the electron energy, which allows the calculation of the binding energy and, 
consequent, identification of the element [130]. 
The XPS analysis was performed on silicon samples coated with Ag and AgxO in a Kratos AXIS Ultra 
HSA equipment, with VISION software for data acquisition and CASAXPS software for data analysis. 
The analysis was carried out with a monochromatic AlKα X-ray source (1486.7 eV), operating at 
15kV (90 W), in FAT mode (Fixed Analyzer Transmission), with a pass energy of 40 eV and a pass 
of 0.1 eV for regions ROI and 80 eV of pass energy and 1.0 eV of step for survey.  Data acquisition 
was performed with a pressure lower than 1*10-6 Pa, and a charge neutralization system was used.  
The effect of the electric charge was corrected by the reference of the carbon peak (285 eV). The 
samples were sputter-cleaned in situ using a broad 2 keV Ar+ beam for 5 min. XPS measurements 
were performed at Laboratório de Análise de Superfícies in CEMUP (Centro de Materiais da 
Universidade do Porto). 
The morphology of Ag and AgxO coatings deposited in SS316L and the thickness of coatings 
deposited on silicon substrates were evaluated by scanning electron microscopy (SEM) analysis in 
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an EDAXNova nano-SEM200 equipment, being analyzed 3 different regions and presented a 
representative micrograph. In SEM analysis, an image is obtained by the interaction of an electron 
beam with the material. This interaction produces a several signals that can be detected, as 
secondary electrons (SE), backscattering electrons (BSE), X-ray and auger electrons, and 
information about material’s morphology and composition (when linked with an energy-dispersive 
X-ray Spectroscopy (EDS) equipment) is obtained [101,131]. SEM top-view micrographs were 
recorded in BES mode at 5kX and thin films morphology were recorded in SE mode at 100kX. 
XRD is one of the most used and powerful characterization technique. This technique allows to 
determinate the crystalline size and access information about the crystal structure. In this 
technique, a monochromatic X-ray radiation is incident on material and it is reflected or diffracted 
by the material crystal planes. This interference between radiation and material’s crystal planes 
results in a diffraction peak, which is reported by the Bragg’s law, as demonstrated in equation 16 
[131]. 
 
𝑛𝜆 = 2𝑑ℎ𝑘𝑙 ∗ sin Θℎ𝑘𝑙 (16) 
  
Where: 
n=Diffraction order; 
λ= X-ray wavelength (nm); 
dhkl= Distance between atomic planes (nm); 
Θ= Angle formed by the incident beam and Bragg considered diffraction plane (⁰). 
 
XRD analysis was carried out in order to understand the structure and phase distribution of the 
coatings, in a PANalytical X´Pert PRO MPD system using CuK radiation (45 kV and 40 mA) with a 
parallel beam configuration. The analysis was performed in grazing incidence mode with an angle 
of incidence of 5°. The X-rays reach the entire sample area, thus only one sample was analyzed, 
which is the common procedure in this technique. The grain size was determined by Scherrer 
formula [132] (equation 17) using the (111) peak in case of Ag thin film. The XRD peak was fitted 
with pseudo-voigt function, which allowed us to calculate either the full-width at half-maximum 
(FWHM) and the peak position (2θ). Silicon substrates were used for XRD analysis.  
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𝛵 =
𝐾𝜆
𝛽 cos 𝜃
 (17) 
 
Where: 
Τ= Mean size of the ordered (crystalline) domains (nm); 
K= Dimensionless shape factor (0.9) 
λ= X-ray wavelength (nm); 
𝞫= Half the maximum intensity (FWHM) (rad); 
Θ= Bragg angle (⁰). 
 
SEM and XRD measurements were performed at SEMAT-UM (Serviço de Caracterização de 
Materiais at Universidade do Minho).  
The coatings hydrophobicity was evaluated through contact angle measurements, using the van 
Oss approach [133] in coatings deposited onto SS316L substrate, using an automated contact 
angle measurement apparatus (OCA 15 Plus; Dataphysics, Germany) located in the Centro de 
Engenharia Biológica at Universidade do Minho. For the contact angle analysis, 8 measurements 
were made, with three different liquids: water, formamide and α-bromonaphtalene, with different 
and known values of surface free energy [59,134], ƳlTot; apolar Lifshitz–van der Waals surface free 
energy component, Ƴllw; electron acceptor surface free energy component, Ƴl+; and electron donor 
surface free energy component, Ƴl- (Table 14). For statistical analysis t-tests were performed, using 
the software GraphPad Prism 6. Tests were performed with a confidence level of 95%.  
   
Table 14- Surface energy components for tested liquids 
 ƳlTot (mJ.m-2) Ƴllw (mJ.m-2) Ƴl+ (mJ.m-2) Ƴl- (mJ.m-2) 
Water 72.8 21.8 25.5 25.5 
Formamide 44.4 44.4 0 0 
α-Bromonaphtalene 58 39 2.28 39.6 
 
 
2.3. Preliminary antibacterial evaluation 
 
A preliminary evaluation of the antibacterial activity, against clinical isolated S. epidermidis (IE 
186), and S. aureus (ATCC 6538) strains, was performed in Centro de Engenharia Biológica at 
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Universidade do Minho, through halo inhibition zone tests, which is a rapid and simple qualitative 
technique for evaluation of antibacterial activity. In this methodology the size of the growth inhibition 
halo around the sample is measured. A colony of each species was taken from a fresh solid bacteria 
culture medium (Tryptic Soy Agar, TSA, Merck) and was added to 20 ml of Tryptic Soy Broth (TSB, 
Merck). Then the resultant suspension was incubated overnight, at 37 ºC and 120 rpm.  A volume 
of 1 ml of 1*107 CFU.ml-1 cell suspension was added to 14 ml of TSA (at 45 ºC) and placed onto 
each petri plate. Then, square samples of stainless steel 316L coated with silver and silver oxide 
were placed in the plates and incubated for 24 h at 37ºC.  All experiments were run in triplicate 
per sample (technical replicates), on three independent assays (biological replicates), for each 
bacterium. The halo, corresponding to the zone of bacterial growth inhibition, formed around the 
sample (Figure 33) was measured. 
 
 
Figure 33- Example of a sample without halo (a)) and a sample with halo (b)). 
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3. Results and Discussion 
 
3.1. Characterization of silver and silver oxide coatings 
 
The coating´s deposition conditions and the oxygen fraction in the discharge (fO2) and input oxygen 
partial pressure pO2,in) are summarized in Table 15. The pure Ag coating was labelled as Ag while 
the Ag coating deposited in reactive sputtering mode was labelled as AgxO.  
 
Table 15- Conditions of coating's depositions and thickness 
Coating 
Ar Flow 
(sccm) 
O2 Flow 
(sccm) 
fO2=
𝞥𝑶𝟐
𝞥𝑨𝒓+𝞥𝑶𝟐
 
pO2, in  
(10-1 Pa) 
JAg 
(mA.cm-2) 
Time 
(s) 
Thickness 
(nm ± S.D.) 
Deposition 
Rate  
(nm.h-1) 
Ag 60 0 - - 2.5 300 55 ± 5 660 
AgxO 60 15 0.2 33.3 1 3600 66 ± 2 66 
 
 
The Ag coating was deposited with 0 sccm of O2, in order to obtain a pure Ag coating, while for the 
silver oxide coating the oxygen flow was selected in order to perform a deposition in reactive mode, 
corresponding to 15 sccm of O2. In Figure 34 it is possible to observe the variation of Ag target 
voltage (already present in section 2.1.) and total pressure in deposition chamber. 
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Figure 34- Variation of Ag target voltage and total pressure in deposition chamber for different fO2  
(at a constant JAg of 1 mA.cm-2). 
 
During reactive sputtering, a reactive gas was introduced to the discharge in order to deposit a 
compound material. For low reactive gas flows, all the gas atoms will react with the metal ejected 
from the target surface and no changes are observed either in the target voltage or in the reactive 
gas partial pressure, which corresponds to the deposition of compound materials in metallic mode. 
However, as the reactive gas flow is further increased, the reactive gas is not totally consumed by 
the growing thin film, which results in an increase in the gas partial pressure and also leads to the 
formation of a compound in the target surface. The variations in target surface condition are 
generally associated with a variation in effective secondary electron emission yield (SEEY), which 
for a constant current density, results in a significant variation on the target voltage [135]. The 
results presented in Figure 34 suggest that both target voltage and total pressure in deposition 
chamber increase at a higher rate when an oxygen flow of 1 sccm (fO2≈0.02) is introduced; 
afterwards the pressure increases linearly, while the target voltage increases up to 8 sccm 
(fO2≈0.12) showing almost constant value after this O2 flow. It should be pointed out that the 
pressure inside the chamber varies from 7.4x10-1  Pa to 9.6x10-1  Pa with the introduction of oxygen, 
while the variations in Ag target voltage are small (varying from 87.3 V to 90 V with the introduction 
of 1 sccm of O2 and up to 92.7 V for 15 sccm), which could turns the identification of reactive 
mode inaccurate. These small variations in Ag target surface condition were somehow expectable, 
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since Depla et al. [136] reported previously that the presence of silver oxide in the target surface 
leads to an increase in the discharge voltage, still, the variation in relation to pure Ag is quite small, 
due to the low relative change of the effective emission coefficient by oxidation of Ag target. 
However, the variations of the target voltage combined with the observations in total chamber 
pressure allowed to predict that above 8 sccm of O2 flow the deposition should be in reactive mode.  
The deposition rate of the thin films was calculated from the ratio of thickness (estimated by SEM) 
with the duration of deposition. Ag coating, deposited with 0 sccm of oxygen flow presented a 
higher deposition rate (0.66 µm.h-1) in relation to the AgxO coating (0.06 µm.h-1), deposited with an 
oxygen flow of 15 sccm. This reduction in coatings deposition rate might be related to the lower 
current density applied to the Ag target combined with the presence of oxygen, which forms Ag xO 
on target´s surface, promoting a lower sputtering yield in relation to pure Ag [137]. 
The deposition time was adjusted in order to obtain a silver and silver oxide films with similar 
thickness (55 ± 5 nm for Ag coating and 66 ± 2 nm for AgxO coating – measured by SEM images).  
XPS analysis was carried out in order to evaluate the coatings chemical binding state. The results 
are shown in Figure 35 where the Ag3d and O1s (inset) spectra of Ag and AgxO thin films are 
depicted. 
  
 
Figure 35 – XPS spectra of Ag3d core levels of Ag-300 and AgxO thin films and O1s spectra of AgxO thin film (inset). 
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The XPS spectra of Ag thin film suggested the presence of a doublet with the Ag 3d5/2 peak at 
368.6 eV, which is reported to correspond to Ag-Ag bond, thus suggesting that Ag coating is in 
metallic state [138–140]. No evidence of Ag-O bonds is visible which was somehow expectable 
due to the low reactivity of silver with oxygen. Regarding the AgxO thin film the Ag3d spectra clearly 
revealed the presence of three distinct bonds: Ag-Ag, Ag clusters and Ag-O, being the third one 
located at 367.7 eV [141].  The XPS spectra of AgxO clearly show that Ag is the main phase and 
only a small contribution of both Ag clusters and Ag-O bonds are visible. The presence of Ag-O 
bond was also visible in the O1s spectra, with a peak at 531.0 (see inset in Figure 35), which 
revealed the presence of Ag-O [142] bond and C-O bond, which is found at higher binding energies, 
being the later associated with surface contamination. The surface contamination inevitably occurs 
when the material surface is exposed to atmospheric conditions, being very easily detected in XPS 
since the depth of analysis is of few nanometers. In fact, the presence of surface contamination 
turns the chemical composition analysis inaccurate; still, the results obtained by XPS revealed that 
the AgxO coating shows an Ag/O atomic ratio of 2.3, a value that could be overestimated, since the 
detected oxygen is a sum of the oxygen present in the coating combined with the oxygen coming 
from surface contamination. This excess of silver is concordant with XPS results, once the content 
of metallic silver is higher than silver oxide component.  
XRD analysis was performed in order to obtain further information about the coatings structure. 
The XRD diffraction patterns of Ag and AgxO coatings are presented in Figure 36 , where the main 
identified crystalline phases are depicted, namely Ag (ICDD card no 00-004-0783), AgO (ICDD card 
no 00-043-1038) and Ag2O (ICDD 00-065-6811).  
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Figure 36-XRD patterns of Ag-300 and AgxO coatings. 
  
The XRD pattern of Ag coating reveals that the coating crystallizes in a FCC-Ag crystal structure. 
According to the calculation obtained by the Scherrer method, for (111) peak, the grain size for Ag 
is about 40 nm. Regarding the AgxO thin film the presence of crystalline Ag phase is evident, 
however a second phase can also be detected, which can correspond to AgO or Ag2O. The results 
obtained in XRD analysis are in good agreement with the XPS analysis, being clear in both 
techniques that the AgxO coating contains a phase mixture of Ag+Ag2O or Ag+AgO. Moreover, the 
Ag/O atomic ratio obtained by XPS was above 2, which means that the amount of oxygen 
incorporated in the coating is not enough to obtain single phased Ag2O or AgO thin films. Pierson 
et al. [87]  have previously reported the formation of Ag and Ag2O phases during reactive sputtering 
of silver in oxygen atmosphere. However, the presence of bi-phase coatings was only observed for 
low oxygen flows, being found that at higher oxygen flows the coatings are composed of a silver 
oxide single phase, being the Ag2O the most common one due to the lower Gibbs free energy 
associated with its formation. In the present report the bi-phase coatings were obtained even in 
deposition in reactive mode, with high oxygen flows.  
The coatings morphology was evaluated through SEM analysis. The SEM top-view micrographs 
(recorded in backscattered electron mode) of Ag and AgxO coatings are presented in Figure 37 (a) 
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and (b), respectively. A more detailed view of Ag and AgxO thin films is shown in Figure 37 (c) and 
(d), respectively. 
. 
 
Figure 37 - SEM top-view micrographs (recorded in BES mode at 5kX) of a) Ag and b) AgxO thin films and detailed view of c) Ag 
and d) AgxO thin film morphology (recorded in SE mode at 100kX). 
 
The SEM micrographs of both Ag and AgxO thin films recorded at low magnification suggest the 
presence of compact coatings surrounded by well-defined interface regions, which correspond to 
the intergranular regions of SS316L substrate. The SEM micrograph of AgxO thin film (see Figure 
37 b)) suggests the presence of some circular features which appear brighter in the BSE 
micrograph, thus suggesting some mass contrast in relation to the matrix coating. These features 
might correspond to Ag agglomerates (showing sizes of several hundred nm) which should appear 
brighter in the BSE images, due to their higher mass in relation to the silver oxide phase, a result 
which is well correlated with the trends observed in XPS and XRD analysis which also suggests that 
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AgxO coatings are composed of two distinct phases: Ag + silver oxide. A more detailed view of AgxO 
thin film (see Figure 37 d)) indicates that the thin film is not continuous being composed by islands 
with hundreds of nanometers in size, surrounded by smaller islands with tens of nanometers. The 
thickness and deposition rate of AgxO thin film reported in Table 15 refer to the smaller islands.  
Conversely, the Ag thin film forms a continuous coating (see Figure 37 c)). Several mechanisms 
have been pointed out to explain the thin films growth from vapor phase, namely:  (i) island (or 
Volmer-Weber), (ii) layer (or Frank –Van der Merwe), and (iii) Stranski-Krastanov, being the 
occurrence of each mechanism dependent on the interaction between the adatoms and the 
substrate. The occurrence of island growth mechanism observed in AgxO thin film occurs when the 
atoms or molecules in the deposit are more strongly bounded to each other than to the substrate, 
which promotes the clustering of metal atoms. As the amount of deposited metal is increased, the 
number of stable nuclei will grow up to a maximum and aftermost diminish due to coalescence 
phenomena, which eventually will lead to the formation of a continuous coating as observed in Ag 
thin film (see Figure 37 c)). Another interesting feature observed in AgxO thin film is the bimodal 
size distribution, being clearly found that the surface is covered by bigger islands with hundreds of 
nanometers surrounded by smaller islands with tens of nanometers. This bimodal size distribution 
suggests the presence of two different phases with different coalescence and growth rates. The 
bigger Ag islands with hundreds of nanometers should correspond to Ag, considering the results 
shown in Figure 37 b), still it is difficult to unequivocally identify to which phases the bigger and 
smaller islands correspond.   
The surface characteristics such as interaction with water and surface free energy play a major 
role in biomedical devices, since numerous physiological events are determined by these surface 
properties. According to the van Oss approach the hydrophobicity of a material is deﬁned by the 
variation of the free energy of interaction (∆G) between the material’s surface (∆m) immersed in 
water (w), ∆Gmwm. When this variation is negative, there is a greater interaction between material’s 
molecules than with water, which leads to a hydrophobic surface.  On the other hand when ∆Gmwm 
is positive the material’s surface is hydrophilic [57].  In addition the water contact angle also allows 
the evaluation of the surface hydrophobic or hydrophilic character, since higher contact angles 
(above 90º[57] or 65⁰ defended for some authors [143]) reveal the presence of hydrophobic 
surfaces, while lower water contact angles imply a more hydrophilic surface [57].  
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The hydrophobicity of a surface plays an important role in microorganism’s adhesion since a higher 
density of apolar areas in material’s surface promote an attachment of microorganism via the 
hydrophobic effect, due to the increment of hydrophobic interactions [144]. 
The contact angles, surface energy parameters and the degree of hydrophobicity of Ag and AgxO 
thin films are presented in Table 16. 
 
Table 16- Water (θw), formamide (θF) and α-bromonaphtalene (θα-B) contact angles, surface energy components (apolar Lifshitz-
van der Waals surface free energy component, Ƴlw ; electron acceptor surface free energy component, Ƴ+; electron donor surface 
free energy Y−; and hydrophobicity (∆Gmwm) of SS316L, silver and silver oxide coatings 
Sample 
Contact angle ±S.D.(º) 
Surface energy 
components (mJ m-2) ∆Gmwm (mJ m-2) 
θw θF θα-B Ƴlw Ƴ+ Ƴ- 
Ag-300 103±2 86±8 43±3 33 0 2 -79±9 
AgxO 103±3 89±6 48±1 31 0 3 -72±10 
 
The water contact angles obtained for Ag and AgxO samples revealed a value higher than 90º, thus 
indicating that all surfaces are hydrophobic, which is also confirmed by the negative ΔGmwm values 
[57]. Moreover, the θw values are statistically similar (t-test, p>0.05) for all surfaces and no great 
variations in ΔGmwm are observed, thus suggesting a very similar hydrophobic character for all 
surfaces. Additionally, coatings present a monopolar surface (Ƴ+=0 and Ƴ-=2 and Ƴ-=3 for Ag and 
AgxO, respectively). 
The coatings’ wettability is dependent on the incorporation of oxygen and films morphology [145]. 
Silver has been reported as present an hydrophobic behavior [59,146]. The incorporation of oxygen 
could lead to a decrease in the contact angle, which is not verified, probably, due to the difference 
morphologies presented by silver and silver oxide coatings [145,147].  
 
3.2. Preliminary antibacterial evaluation: Halo Test 
 
Halo inhibition zone tests were performed in order to assess the coatings antibacterial efficiency 
against S. epidermidis and S. aureus. The results obtained for three tested coatings against these 
two types of bacteria are presented in Figure 38. 
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Figure 38 - Results of antibacterial tests for SS316L (a)), Ag(b)) and AgxO (c)) regarding Staphylococcus epidermidis (I)) and 
Staphylococcus aureus (II)). 
 
Concerning the antibacterial tests, the results were similar for both bacteria. In Figure 38 a) and 
b) it is possible to observe that the bacteria grew all around the uncoated SS316L and  Ag coating 
(no inhibition halo formation was observed). Nonetheless, coating AgxO (Figure 38 c)) presented 
halo around the sample, which means that there is an inhibition zone of bacteria growth. However, 
for S. epidermidis (Figure 38 c) I)) the halo presented for these samples is completely clear in the 
zone nearby the sample and became less clear when it moves away, which suggest that there is a 
zone of non-growth of bacteria (clear halo) and a zone of inhibition of bacteria growth (diffuse halo), 
which may be due to the silver released to the agar medium. For S. aureus there is not visible a 
clear halo, which indicates that there is a zone of inhibition of bacteria growth but there is not a 
complete death of bacteria. Similar results, where S. epidermidis presented more sensibility to 
silver than S. aureus has been previously reported [148–150]. Silver sensitivity of microorganisms 
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depends on species- or even strain-specific mechanisms reflecting differences in metabolizing silver 
or repairing silver-related cell damages [149].  
The contact angle measurements suggested that Ag and AgxO coated SS316L present very similar 
surface characteristics (surface energy parameters and the degree of hydrophobicity), in this sense, 
the differences in biological properties cannot be attributed to any changes in surface properties. 
Therefore, the different behaviors can only be attributed to the Ag antibacterial activity, which 
seems to be different in Ag and AgxO thin films. Recently, proteomic analysis revealed that even a 
short exposure of silver nanoparticles to bacterium cells resulted in alterations in the expression of 
a panel of envelope and heat shock proteins. Ag nanoparticles can penetrate and disrupt the 
membranes of bacteria, providing a loss of intracellular potassium. Furthermore, Ag nanoparticles 
decreased the ATP levels, which culminates with the death of bacteria [151,152]. Similar results 
can be observed with silver ions. Although pure metallic silver is stable in usual conditions and, 
consequently, has low solubility in water [125], when in contact with bacteria, some chemical 
compounds, that facilitate the release of Ag+ ions, are formed and, therefore, increase the 
antibacterial activity [153,154]. Ag+ ions penetrate the bacteria cell wall and bind to phospholipid 
layer of the cytoplasmic membrane and to bacteria DNA disrupting its replication [155]. Regarding 
the antibacterial results, it is clear that there is antibacterial activity only in AgxO sample. So, these 
results suggest that the form of silver (NP’s; clusters; islands or continuous films) could have 
influence on the antibacterial efficacy; in addition, the presence of silver oxide matrix could promote 
the release of silver. In Figure 39 a possible mechanism of Ag dissolution when in contact with 
bacteria is represented, for both studied coatings: AgxO (which surface is composed of islands 
combined with smaller Ag particles) and Ag (which form a continuous thin film). 
 
 
Figure 39-Schematic illustrations of possible mechanisms of Ag dissolution, with and without Ag nanoparticles, when in contact 
with bacteria (adapted from [154]). 
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Althgouth the mechanism of silver release from metallic surfaces is poorly understood [156], the 
silver form plays an extremely important role in antimicrobial behavior of silver based surfaces. In 
fact, the Ag thin film which formed a continuous layer based on crystalline Ag phase did not show 
any evidence of antibacterial activity, conversely the AgxO thin film which is composed of islands 
and small Ag particles, being mainly composed by a mixture of Ag and silver oxide crystalline 
phases, showed indication of antibacterial activity. As previously mentioned,the activity of 
nanosilver is predominantly associated with the presence of Ag+ ions and also to small Ag 
nanoparticles, which tend to be more easily ionized [157], being also claimed that they are able to 
directly interact with bacteria promoting their destruction.  The presence of silver clusters and silver 
agglomerates in AgxO sample (see Figure 37 d) results in a higher exposed surface area when 
compared with continuous Ag layer, consequently, a higher release of Ag+ ions could be expected 
when the surface is exposed to the TSA and bateria medium. 
 
4. Partial Conclusion 
 
Silver and silver oxide thin films were deposited by non-reactive (for Ag thin film) and reactive (for 
AgxO thin film) pulsed dc magnetron sputtering in order to assess the coatings antibacterial activity 
against S. epidermidis and S. aureus, two of the most common bacteria associated with 
nosocomial infections found in cardiovascular stents. The structural and morphological 
characterizations revealed that Ag thin film forms a continuous layer, while the incorporation of 
oxygen in the deposition atmosphere lead to the formation of a thin film composed by a mixture of 
two crystalline phases: Ag and silver oxide. The latter thin film was characterized by the presence 
of islands with several hundreds of nanometers surrounded by smaller particles with tens of 
nanometers. The halo inhibition zone tests revealed the antibacterial behavior of AgxO thin films 
against both of the tested bacteria; conversely no antibacterial effect was found in Ag thin film, as 
summarize in Figure 40.  
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Figure 40- Summary of production and characterization of developed silver and silver oxide thin films. 
 
The differences between these two coatings might be related not only to the presence of silver 
oxide phase, but also to the differences found in coatings growth mode; with Ag coatings forming 
a continuous layer and AgxO forming islands surrounded by smaller nanoparticles. These 
differences might lead to better interaction between the thin film surface and bacteria, due to the 
higher surface to volume ratio, which can increase the Ag ionization rate or the direct interaction 
between Ag and bacteria. The obtained results suggest that AgxO coating, deposited by reactive dc 
magnetron sputtering, present antibacterial properties for both bacteria used and it has great 
potential to be applied in cardiovascular stents. However, it is still unclear if the chemical 
composition was responsible for the antibacterial activity or it was only the morphology on islands 
that promotes an antibacterial action. Thus, in order to evaluate, more accurately, what is in fact 
controlling the antibacterial efficacy of AgxO, a detailed study about AgxO thin films is necessary. 
Next chapter will be focus on the influence of the introduction of the oxygen on silver coatings on 
the structural and consequent antibacterial activity.  
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1. Introduction  
 
Taking in account the results obtained for silver oxide coatings and keeping in mind that silver 
oxides systems have not been well studied, since silver is, generally, consider as a non-reactive 
material [86], it was important to study the influence of the oxygen content.  
Regarding silver oxide synthesis, the most popular method is evaporation of metallic silver following 
by an oxidation, in a reactive environment (normally, a reactive plasma excited by dc magnetron 
or microwave), or sputtering [86]. Nevertheless, only few reports of the application of magnetron 
sputtering in the formation of silver oxides, and consequently combination of the advantages of 
magnetron sputtering technique and reactive processes [73], especially the controlling in the 
reactive gas and, consequently, film’s composition, have been published. The formation of these 
oxides in form of thin films, depends on the availability of oxygen in the deposition chamber and 
the energy required for the oxidation, i.e., growth conditions/reaction kinetics [158]. The synthesis 
of metal oxide films, by reactive magnetron sputtering, can be achieve by two distinct mechanisms: 
i) sputtering of the material from the target and its condensation on the substrate or ii) chemical 
reaction between the condensing material and reactive gas species. In the second mechanism, the 
target is sputtered in metallic mode, an higher yiel is promoted and an higher deposition rate is 
achieved [127]. 
Barik et al. [159], for instance, studied silver oxides prepared by reactive dc magnetron sputtering, 
operating in constant power mode at 25 W observing that at oxygen flow of 1.71 sccm and 2.01 
sccm a stoichiometric Ag2O (FCC) was formed. Additionally, Raju et al. [158]  also evaluated the 
influence of oxygen partial pressure changes during films growth, by pulsed laser deposition (PLD), 
revealing that with the increase of the oxygen pressure from 9 to 50 Pa, in the deposition chamber, 
an Ag2O phase transforms into AgO. In their study, only oxygen pressure was varied, maintained 
the others growth parameters constant: temperature (300K), fluence (1.006 J.cm-2), substrate-
target distance (3 cm) and deposition time (90 min). For an oxygen pressure of 9 Pa, a pure Ag2O 
hexagonal crystal system was formed. As chamber pressure increases, an AgO monoclinic crystal 
system began to appear. For 10 Pa it was observed a mixture of AgO and Ag2O and for pressures 
higher than 20 Pa only AgO was formed. Dellasega et al. [160] obtained pure AgO (at higher 
fluence: 1.6 J.cm-2) and conclude the threshold pressure to obtain AgO was 4 Pa. Furthermore, 
Kumar et al. [88] deposited AgO thin films by RF reactive magnetron sputtering, with a sputtering 
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power of 50W, at room temperature, with oxygen flow rates from 10 sccm to 30 sccm. The results 
showed an uniform and stoichiometric AgO (monoclinic crystal system), oriented along the (-111). 
Silver oxide coatings can be an advantage in antibacterial properties of coatings, once, as previously 
refered, despite silver being a well-known antimicrobial agent, and having a broad-spectrum of 
activity, its mechanism of action is not fully understood [72,73]. However, it is suggested that the 
antimicrobial behavior of silver can be achieved by: i) the release of Ag+ ions, ii) the interaction of 
bacteria with silver nanoparticles and iii) the formation of reactive oxygen species (ROS) 
[53,57,61,74].  
ROS can be generated inside or outside the cell and are byproducts of respiring organisms’ 
metabolism. Induction of ROS formation leads to the synthesis of highly reactive radicals that can 
cause the mitochondrial damage of the microorganism, accelerating the cell death or dysfunction. 
It is reported that silver can generates ROS, potentially including superoxide (O2•-), hydroxyl radicals 
(•OH.), singlet oxygen (1O2) and the most stable ROS (H2O2) [85]. 
Hence, it should be also possible to improve silver antibacterial characteristics by forming reactive 
oxygen species, which leads to a most effective antibacterial behavior of silver, due to the toxic 
character of these species to bacterial cells, as demonstrated by Ferreri et al. [72] that used 
oxidized nano-silver to achieve antibacterial behavior.  
Thus, it is important to evaluate the influence of oxygen content on the functional properties of the 
films, namely the antibacterial effect. As a result, the main objective of this part of the work is to 
produce and characterize silver and silver oxides thin films, by reactive magnetron sputtering,  with 
the main aim of designing a coating that provide antibacterial properties to medical devices such 
as cardiovascular stents. The oxygen flow variation, during the coatings deposition process, was 
studied, in order to understand the influence of the oxygen content on the physical, chemical and 
structural properties of coatings and its effect on the antibacterial activity against S. epidermidis, 
since this bacterium showed more sensitivity to silver oxide antibacterial properties. 
 
2. Materials and Methods 
 
2.1. Production of silver and silver oxide coatings 
 
Ag and AgxO coatings were deposited onto stainless steel 316L and silicon substrates by reactive 
pulsed dc magnetron sputtering. In order to remove impurities and minimize contamination, 
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substrates were ultrasonically cleaned with distillate water, ethanol and acetone, during 10 minutes 
in each solution, before deposition. Additionally, similar to previously depositions, the substrates 
and the silver target (200 x 100 mm2) were cleaned by an argon plasma etching process prior to 
each deposition. The etching process was performed in an argon atmosphere (80 sccm), using a 
pulsed dc power supply at 0.4 A, 1536 ns of reverse time and 200 kHz applied to the substrate 
holder and a dc power supply, with a current density of 0.5 mA cm-2, applied to the Ag target.  
During the deposition process, the sputtering atmosphere consisted of a constant argon flow (𝝫Ar 
= 60 sccm) and an O2 flow (𝝫O2) that varied from 0 scmm to 15 sccm, (increasing 1.5 sccm per 
deposition), corresponding to a variation in the fraction of oxygen in the discharge [127] (fO2 = 𝝫O2 
/(𝝫O2 + 𝝫Ar) from 0 to 0.2). Total pressure inside the chamber varied from 5.8x10-1 Pa until 
7.8x10-1 Pa, with the increase of the O2 flow. A pulsed dc power supply was connected to the silver 
target, applying a current density of 1 mA.cm-2, and the reverse time and the frequency were kept 
at 1536 ns and 200 kHz, respectively. The samples were placed in a substrate holder, located 70 
mm away from the target and rotating at a constant velocity of 7 rpm. The deposition time (8 h) 
was maintained constant for all the coatings. Deposition process was performed at room 
temperature. Silver oxide coatings deposited in reactive sputtering mode were labelled as AgO 
following by the percentage of O2 flow used in the deposition, while silver coating was labelled as 
Ag. Thus, AgO10 corresponds to a deposition with 10% of the total O2 flow (corresponding to 1.5 
sccm) AgO20 corresponds to a deposition with 20% of the total O2 flow (corresponding to 3 sccm), 
etc. 
  
2.2. Characterization of silver and silver oxide coatings 
 
Regarding coatings’ characterization, and similar to section 2.2. of Chapter III, XPS analysis was 
performed on coated silicon, in order to obtain information about binding state of the samples. 
However, it should be pointed out that no previous sputter cleaning was performed before the XPS 
analysis in order to avoid the preferential sputtering of oxygen. The morphology and thickness of 
the coatings deposited on silicon, were evaluated by SEM in a NanoSEM – FEI nova200 equipment, 
being analyze three different regions, but only present a representative micrograph. EDS was 
performed for the detection of coatings bulk composition, with an energy of interaction between 
electron beam and material of 10 keV. Despite the use of EDS for chemical composition, it is widely 
known that the quantification of oxygen is not always accurate with EDS and the thickness of 
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samples is to low, once the interaction of electron beam and the sample can be 1 micrometer. 
However, a correlation between all the results from XRD, XPS and EDS is made, in order to 
elucidate the type of oxide present in the samples. Thus, the procedure followed to obtain accurate 
composition should be interpreted as the combination of the techniques, where the XRD shows the 
crystalline phases, the XPS the bonding states of the elements and the EDS a ratio between the 
content of O and Ag.  EDS measurements were performed at SEMAT-UM (Serviço de 
Caracterização de Materiais at Universidade do Minho).  
Structure and phase distribution of coatings was assessed by XRD analysis in a PANalytical X’Pert 
PRO MPD system, using CuKα (λ=0.154056nm), as previously described in section 2.2 of Chapter 
III. 
Contact angle measurements were performed with the view to investigate the samples hydrophobic 
behavior, using the van Oss approach, in 8 measurements of each coating, through the sessile 
drop contact angle technique, using an automated contact angle measurement apparatus (OCA 
15 Plus; Dataphysics, Germany). For this purpose, water, formamide and α- bromonaphtalene 
were used, as already described in section 2.2 of Chapter III. For statistical analysis, one- way 
ANOVA analysis was used, by applying Tukey multiple comparisons test, using GraphPad Prism 6 
software. All tests were performed with a confidence level of 95%. 
  
2.3. Preliminary antibacterial evaluation 
 
Halo inhibition zone tests, against S. epidermidis (IE 186), were performed in order to evaluate, as 
a qualitative measure, antibacterial activity. The conditions of the tests were described in section 
2.2 of Chapter III.  All the assays were run in triplicate. 
Furthermore, ICP-OES (inductively coupled plasma optical emission spectrometry) was performed 
in order to quantify the silver ion release from coatings. With that intuit, coated SS316L were placed 
in a falcon with 50 mL of 0.95 (w/v) NaCl and incubated at 37 ⁰C, for 24 h. After that, 2 mL of 
this solution was taken and diluted in 4 mL of 5% (w/v) HNO3, once this acid could lead to the 
formation of AgNO3 and the production of more Ag ions. Previously, a calibration curve was 
prepared, using silver standard solution for ICP. The release of Ag ions was measure using a 
PERKINELMER, ICP-OES OPTIMA 8000, with a 6106PE POLYSCIENCE refrigerator and a S10 
PERKINELMER automatic sampler. All the tests were run in triplicate and performed at Centro de 
Engenharia Biológica at Universidade do Minho. 
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3. Results and Discussion 
 
3.1.     Characterization of silver and silver oxide coatings 
 
The variation of Ag target voltage and pressure in deposition chamber according with the fraction 
of oxygen is presented in Figure 41. It reveals that the target voltage increases up, with a tendency 
to stabilize, from 86.9 V up to 92.4 V. As the fO2 increased, an increase in the total pressure and 
in the silver target voltage is observed, once the reactive gas is not totally consumed during the 
growth of thin films, which leads to a formation of a compound (Ag-O) in the target surface, 
associated with a variation in effective secondary electron emission yield (SEEY), reaching a 
poisoned mode.  
 
 
Figure 41- Variation of Ag target voltage and total pressure in deposition chamber for different oxygen fractions in the discharge. 
 
The deposition rate of the films (see Figure 42) was calculated from the thickness (observed by 
SEM) and deposition time, revealing an increase for the film deposited with the lowest oxygen flow 
rate and continuously decreasing as oxygen is incorporated. This behavior is attributed to the 
introduction of oxygen, which in an initial phase, contributes along with silver films growth, leading 
to an increase of deposition rate with the introduction of oxygen. However, for higher amounts of 
oxygen, silver target is poisoned with oxygen, leading to deposition of silver oxides, and, 
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consequently, to lower deposition rates, once silver oxides have lower sputtering yield, when 
compared with pure silver [137]. A closer look on the deposition rate for the Ag film on this series 
of samples ( 20 nm.h-1) indicates that the deposition rate is clearly lower than the deposition rate 
for the Ag film, from previous series ( 660 nm.h-1). The differences cannot be explained by the 
differences on the current density, which change from 1 mA.cm-2 to 2.5 mA.cm-2. Even the target 
condition, cannot be claimed so different, since the target potential change from 86.9 to 250 V, 
somehow expected by the increase on the current density. However, it seems clear that the low 
deposition rate of Ag film on this section should indicate that the target current density applied can 
be in the limit of the plasma maintenance. 
Regarding the silver oxide samples with higher content of oxygen (fO2=0.2) in both series, 
differences in deposition rates can be observed. As reported by Snyders et al. [127] partial pressure 
of oxygen influences the conditions of deposition and the deposition rate,  and the partial pressure 
of oxygen are in fact different in both series. In previous series the input oxygen partial pressure 
was 1.50*10-1 Pa while in this series was 1.60*10-1 Pa. This difference can leads to different 
conditions in the target and in the mean free path, leading to different deposition conditions and, 
consequently, to a different growth of the film. 
 
 
Figure 42 -Variation of deposition rate for different oxygen fractions in the discharge. 
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A bulk composition of the coatings was performed by EDS analysis, indicating an excess of silver 
for AgO10 and AgO20 coatings, while for the remaining coatings the amount of silver and oxygen 
are similar, suggesting an AgO composition (Figure 43 and Table 17).  
 
 
Figure 43-EDS composition for silver and silver oxide coatings 
 
Figure 41 reveal that with the increase of the fraction of oxygen in the discharge, the pressure in 
the chamber increases linearly in the entire range of oxygen fraction. The increase of oxygen also 
leads to an increment in the Ag target voltage, but the voltage stabilizes, approximately after fO2= 
0.09. The same tendency is observed (see also Table 17) in atomic composition of the coatings, 
where the percentage of oxygen increases, until fO2= 0.09, stabilizing after that. 
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Table 17-Thickness and of Ag/O ratio composition of silver oxide coatings 
Nomenclature 
O2 flow 
(%) 
O2 flow 
(sccm) 
pO2,in  
(10-1Pa) 
fO2=
𝞥𝑶𝟐
𝞥𝑨𝒓+𝞥𝑶𝟐
 
Ag/O 
ratio 
Thickness 
(nm) 
Ag 0 0 - - - 160 
AgO10 10 1.5 0.12 0.02 2.0 329 
AgO20 20 3 0.24 0.04 1.7 253 
AgO30 30 4.5 0.46 0.07 1.1 219 
AgO40 40 6 0.60 0.09 1.2 242 
AgO50 50 7.5 0.76 0.11 1.1 185 
AgO60 60 9 0.92 0.13 0.9 146 
AgO70 70 10.5 1.08 0.15 1.1 166 
AgO80 80 12 1.26 0.17 1.0 163 
AgO90 90 13.5 1.37 0.18 1.0 175 
AgO100 100 15 1.60 0.20 1.0 195 
 
SEM results (Figure 44) suggest the presence of a compact film in Ag coating contrary to AgxO 
coatings that present some porosity. AgxO coatings show a more columnar structure, compared to 
the pure Ag coating; however, the increase of oxygen fraction minimizes the porosity, producing 
more compact films and with lower column size. Comparing the silver oxide coatings with silver 
oxide thin film from the previous series of samples it is clear that they present different 
morphologies, once the two series present different deposition (in first series of samples it was 
3600 s while in the second series of samples it was 28800 s). 
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Figure 44 -SEM films cross section detailed view (recorded in SE mode at 100kX) and top-view micrographs (recorded in SE 
mode at 100kX) (a) to f) referent to Ag, AgO10, AgO20, AgO50, AgO80 and AgO100, respectively. 
 
In order to obtain a more detailed information about the coatings structure, XRD analysis was 
performed. The XRD diffraction patterns of Ag, AgO10, AgO20, AgO40, AgO60, AgO80 and AgO100 
coatings are presented in Figure 45. The XRD spectrum evidenced three different structures in the 
films. The Ag films present a typical face-centered cubic (FCC) polycrystalline structure (ICDD card 
no 00-004-0783), with randomly oriented crystallites with grain sizes of 79 nm, calculated by 
Scherrer formula (equation 17).  
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Figure 45-XRD patterns of Ag and AgxO coatings, according to ratio of Ag/O composition estimated by EDS. 
 
For AgxO films, on the other hand, two distinctive behaviors are noticed. For large oxygen fractions 
(AgO40 to AgO100), a monoclinic AgO phase is easily identified (ICDD card no 00-043-1038), 
which is in agreement with the composition of the films, where the ratio between Ag and O is close 
to the unit, as previously discussed. Once again, a different behavior can be observed when 
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compared this series of oxide silver samples with the first series of samples. In this series, for 
samples with higher content of oxygen, a stoichiometric silver oxide, seems to be achieved, which 
not occurred in the previous series. Afresh, the conditions in two depositions series are different.  
Nonetheless, for low oxygen fractions (AgO10 and AgO20) at least two scenarios can be 
considered. In the first case, a pure monoclinic AgO phase was fitted, where residual stresses in 
the films may slightly increase the lattice parameter. This variation results in a shift of the (002) 
plane towards lower angles. The simulation predict a variation from 0.549 to 0.559 nm, in the 
lattice parameter, which is likely to occur for grains preferentially orientated in the (002) direction 
and films in compressive stress. These results can simulate the spectra obtained for sample 
AgO10. Yet, there is still a lack of fit for AgO20, where the diffraction peak corresponding to 56.3 
degrees is not included in the fitted spectrum, as shown in Figure 46 a). Additionally, the excess 
of silver in those films would not explain the pure AgO phases.  
As a result, a second scenario is proposed, considering a mixture of Ag2O FCC (ICDD card no 00-
043-0997) and monoclinic AgO phases and the result are shown in Figure 46 b). In this case, the 
diffraction occurring at 56.3 degrees is included as the (022) diffraction of the Ag2O phase, 
decreasing the fitting deviation. However, the cell parameter for the cubic structure showed a slight 
deviation from the theoretically value, showing a difference of 0.009 nm (from 0.471 nm to 0.463 
nm). This variation may be due to the lack of stoichiometry of the compound, where instead of 
pure Ag2O, an AgxO phase is formed. This has been previously reported in silver oxide 
nanostructures [161]. 
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Figure 46-AgO20 XRD pattern fitted using a monoclinic AgO structure, b) AgO20 XRD pattern fitted using a mixture of Ag2O and 
AgO phases. The symbols correspond to the experimental results and the color lines to the fitted lattice planes for the identified 
structures. 
 
Considering the previous analysis, silver oxide coatings AgO10 and AgO20 are identified as a 
mixture of sub-stoichiometric AgxO FCC phase, with composition close to Ag2O, and AgO monoclinic 
phases. For higher oxygen fractions (AgO40 to AgO100), Ag2O disappears and coatings only present 
a single AgO monoclinic phase. These results are in agreement with the composition of the films, 
where for high oxygen fractions there is sufficient oxygen to form a pure AgO compound, as 
previously mentioned. The difference observed in silver oxides, with the increase of oxygen fraction, 
can be justified by the availability of oxygen in the reaction zone, resulting in the formation of 
different valence states of metal oxide [158].  
According to Figure 41 and the compositional, structural and morphological results presented, four 
samples were chosen to continue the study of chemical bonding and antibacterial characterization 
(Ag, AgO10, AgO20 and AgO100). The remaining samples were discarded for further analysis due 
to their similar composition, morphology and structure with samples AgO100.  
In order to confirm the chemical state and binding energy of the coatings surface and the phase 
composition, XPS analyses were carried out. Nevertheless, XPS analysis of silver and silver oxides 
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is very complex, once the binding energies of metallic silver and its oxides are reported with low 
dispersion of values, or even superposition.  
In order to facilitate the identification of oxidation states, the Auger Parameter (AP) was used, since 
it is considered to be more reliable that finding the correct binding energy of each state of oxidation 
[140]. AP does not depend on the sample charge shift, avoiding charge correction, and AP peaks 
present larger chemical shifts than photoelectron peaks [140]. Despite the fact that this parameter 
allows distinguishing the reduced form Ag0 from its oxidized forms, it cannot distinguish Ag (I) form 
from other oxidation states, and thus other parameter such as the FWHM of the peak should be 
considered. Hence, XPS analysis of coatings were carried out with binding energy for Ag3d and 
kinetic energy for Ag MNN, as observed in Figure 47.The bonding types, binding energies, APs and 
possible structures are summarized in Table 18. 
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Figure 47-XPS survey spectra and detailed regions of Ag3d (left) and Ag MNN (right) for Ag and AgOX thin films. 
 
Table 18-XPS analysis of different coatings [140,162–164] 
Coating Bonding 
Binding 
Energy (eV) 
Auger 
parameter 
(eV) 
Compatible 
with: 
Ag Ag-Ag 368.86 726.09 Ag 
AgO10 Ag-O 368.28 723.36 AgO/Ag2O 
AgO20 Ag-O 368.28 723.41 AgO/Ag2O 
AgO100 Ag-O 368.31 723.37 AgO/Ag2O 
 
For Ag coating, the spectra suggest the presence of a doublet with the Ag 3d5/2 peak located at 
368.86 eV. This fact, combined with auger parameter, is reported to correspond to Ag-Ag bond in 
metallic state [139,164]. On the other hand, Ag-O bonds at 368.28eV [165], for transition mode 
coatings (AgO10 and AgO20), and at 368.31 eV for the coating in the reactive mode (AgO100). 
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These binding energies are compatible with silver oxides. According to Ferraria et. al  [140], the 
doublet assignable to Ag 3d have different characteristics in AgO, Ag2O and in a mixture of those 
two phases, regarding binding energy and FWHM. In fact, the Ag 3d doublet, reported in such 
study, is slightly shifted in AgO coating (0.4±0.1 eV) and presents the largest FWHM, when 
compared with a mixture of Ag2O and AgO powders [140]. This behavior is observed in sample 
AgO100, when compared to AgO10 and AgO20 coatings, as shown in Figure 47 ,supporting the 
idea of a mixture of AgO +Ag2O phases for AgO10 and AgO20 coatings and a single AgO phase for 
AgO100 coating, observed by XRD, and corroborated by compositional analysis. 
Furthermore, XPS spectra to O 1s and C 1s are presented in Figure 48. Some residual oxygen and 
carbon are associated with surface contamination, since no previous sputter cleaning was 
performed in order to avoid preferential sputtering of O and any structural damage in the coatings. 
Additionally to the contamination, O-Ag peak (529.3 eV), associated to the bonding of silver oxide, 
was identified in the AgOx coatings, which has been reported to shift to lower binding energies for 
pure AgO phases, observed in AgO100 coating, when compared with Ag2O and their mixture [140]. 
 
 
Figure 48- XPS O1 (left) and C 1s (right) spectra for Ag and AgXO thin films. 
 
As referred in section 3.1 of Chapter III, the measurement of contact angle allows the evaluation 
of the hydrophobicity character of a surface. Table 19 shows the contact angles, surface energy 
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parameters and degree of hydrophobicity of all the coatings. The results evidence that all coatings 
present a hydrophobic surface, since the water contact angles are above 90⁰ and ∆Gmwm present 
negative values. AgO100 coating is statistically different from the others (p<0.05).  
By the literature the wettability of coatings is strongly dependent on the oxygen partial pressure 
and films morphology [145,147]. 
Regarding silver oxide thin films, different states of oxidation of the films leads to changes in their 
affinity toward water. Mirzaeian et al. [147] reported that the increase in oxygen flow rate increases 
the wettability of the films toward water, due to further, changes in the electronic properties of the 
surface caused by the increase in the oxidation state of the films. This is a result of clustering of 
electrons in polar molecules of water around the oxides at a higher oxidation state.  
However, as discussed by SEM micrographs before, higher oxygen flow rates result in smooth and 
dense films which leads to a slightly decrease on the wettability with water, as observed to AgO100 
coating. 
Additionally, all coatings present a monopolar surface. Higher density of apolar areas in material’s 
surface can promote an attachment of microorganism via the hydrophobic effect, due to the 
increment of hydrophobic interactions [144]. 
 
Table 19-Water (θw), formamide (θF) and α-bromonaphtalene (θα-B) contact angles, surface energy components (apolar Lifshitz-van 
der Walls surface free energy component, Ƴlw ; electron acceptor surface free energy component, Ƴl+; electron donor surface free 
energy component, Ƴl- 
Coating 
Contact Angle ± S.D.(º) 
Surface energy 
components (mJ.m-2) 
∆Gmwm 
(mJ.m-2) 
θw θF θα-B Ƴlw Ƴ+ Ƴ- 
Ag 102±1 95±2 53±1 28.7 0.0 5.1 -57±4 
AgO10 101±3 88±6 44±2 32.6 0.0 3.3 -68±6 
AgO20 99±4 87±1 40±1 34.4 0.0 4.4 -63±5 
AgO100 107±2 90±3 50±3 29.9 0.0 1.1 -82±9 
 
3.2. Preliminary antibacterial evaluation 
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Halo inhibition tests were performed in order to evaluate the existence of antibacterial properties 
of the coatings, against S. epidermidis. The results obtained are present in Figure 49. A halo zone 
(zone of inhibition of bacteria growth) in oxide coatings is clearly observed. On the other hand, in 
Ag coating the halo is not visible, which means the pure Ag continuous film did not present 
antibacterial activity against S. epidermidis.  
 
 
 
 
Figure 49-Results of antibacterial tests for: Ag (a)); AgO10 (b)); AgO20 (c)) and AgO100 (d)). 
 
As previously suggested, the form of silver can influence the antibacterial efficiency. The presence 
of Ag nanoparticles tends to ionize more easily, when compared with a compact film, and also 
interact, directly, with bacteria, promoting their destruction [157]. Once in studied coatings there 
is no evidence of silver nanoparticles, the antibacterial behavior of the silver oxide coatings should 
be due to a higher silver ion release of those coatings. In order to verify the amount of silver ions 
release of the coatings, ICP-OES was performed after 24 h period of contact of coatings with NaCl 
0.9%. In Figure 50 it is possible to analyze the Ag+ release from coatings and it is possible to observe 
that silver oxides did not present a high silver ion release, which means that are not the silver ions 
the direct responsible from the different antibacterial characteristics presented by silver and silver 
oxides coatings.  
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Figure 50- Results of ICP-OES test. The data are expressed as mean ± standard deviations. One way ANOVA was used with 
significant level of 95% (* p<0.05). 
 
In Chapter III it is shown that in silver thin films, Ag ionization is insufficient or non-existent and, 
consequently, no antibacterial activity was observed, contrary to AgxO thin films. In this series of 
samples, the same results are achieved (only silver oxide samples presented antibacterial activity). 
However, once there is not higher silver ionization in silver oxide coatings, when compared to silver 
coatings, and no nanoparticles are present in this series of sample, it should be the presence of 
the silver oxide the responsible for the antibacterial behavior of silver oxide thin films.  
By the literature it has been proposed that it is the specific characteristics of silver morphology the 
main responsible for the production of ROS and silver oxide promotes the formation of ROS 
[54,74,162].  So, according with ICP-OES and halo tests results, it is suggested that the formation 
of ROS (equation 18) [74] is, probably, the agent responsible for the antibacterial properties of 
silver oxides. 
 
𝐴𝑔 + 𝑂2 → 𝐴𝑔 … 𝑂2 →
𝐻+ 𝐴𝑔+ + 𝑅𝑂𝑆 +  𝐴𝑔 → 𝐴𝑔+ + 𝐻2𝑂  (18) 
 
Ninganagouda et al. [163] demonstrated that Ag nanoparticles when in contact with bacteria 
inhibited their growth, due to ROS formation. However, when it was added an antioxidant to Ag 
nanoparticles, the antibacterial behavior was not observed. This study determined that the 
antioxidant agent prevented the formation of a silver oxide layer on Ag nanoparticles’ surface, and 
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consequently, inhibited the antibacterial activity. Thus, the use of a silver oxide coating can be an 
advantage in ROS formation and explain antibacterial results.  
Furthermore, as demonstrated by Ferreri et al. [72], the incorporation of oxidized silver on coatings 
can inhibit the bacterial growth, since allows the synthesis of OH- in aqueous environments 
(equation 19 and equation 20). 
 
𝐴𝑔2𝑂 + 𝐻2𝑂 ↔ 2𝐴𝑔
+ + 2𝑂𝐻− (19) 
𝐴𝑔𝑂 + 𝐻2𝑂 ↔ 𝐴𝑔
+ + 2𝑂𝐻− (20) 
 
Antibacterial tests demonstrated that the formation of reactive oxygen species could be the 
principal motive to achieve antibacterial properties, since silver oxide coatings presented 
antibacterial activity unlike continuous silver coating.  
 
4. Partial Conclusions 
 
Ag and AgxO coatings were deposited by non-reactive and reactive pulsed dc magnetron sputtering, 
respectively. The O2 flow and, consequently, oxygen fraction during the deposition process, was 
varied in order to evaluate the influence of oxygen species in coatings properties.  
The structural and morphological characterizations revealed that Ag coating forms a continuous 
layer, composed by crystalline FCC-Ag phase. The incorporation of oxygen in the deposition 
atmosphere leads to the formation of a coating composed by a mixture of Ag2O+ AgO phases. As 
the amount of oxygen fraction increase, the observed thin film became, only, AgO, with a 
monoclinic crystalline phase. 
Halo inhibition testes revealed the antibacterial behavior of AgxO coating unlike Ag coating. The 
differences on coating behavior may be attributed to film composition (the incorporation of oxygen 
leads to a higher formation of ROS and, consequently, to an antibacterial behavior), as summarized 
in Figure 51. 
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Figure 51-Summary of the variation of the oxygen content and its influence on film’s characterization and antibacterial 
properties. 
 
The results suggest that AgxO coating deposited by dc magnetron sputtering have potential to be 
used in coronary stents. 
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1. Introduction 
 
Taking into account the disadvantages of commercial metallic stents previously reported, there is 
a growing need for the development of biocompatible stents that avoid the corrosion and restenosis 
events associated to metallic stents and polymeric coatings. Additionally, apart from restenosis, 
coronary stent infection has been described as an unusual but severe complication of coronary 
artery stenting procedures with associated alarmingly high mortality [166–169].  
As mention in Chapter II, a polyester stent (PES270A35D6) was developed and presented good 
mechanical properties (0.23 N of force in longitudinal compression, 1.29 N of force in radial 
compression, 80% of porosity and 85,5% of unchanged diameter in bending tests), when compared 
with nitinol commercial stents. Furthermore, considering the promise results in antibacterial 
activity, against Gram-positive Staphylococcus epidermidis, for silver oxide coatings developed in 
Chapter III and Chapter IV, in this chapter we intend to functionalize the PES270A35D6 stent with 
silver and silver oxide coatings.  The mechanical properties of the coated stent, the coating’s 
performance when subjected to mechanical tests, the obtained antibacterial properties as well as 
the biocompatibility will be thoroughly studied. 
The ultimate objective of this study is to achieve the optimal conditions for obtaining a fibrous stent 
that fulfil the mechanical requirements when compared with commercially available nitinol stents 
and provide it with antibacterial properties [14]. 
 
2. Materials and Methods 
 
2.1. Production of silver and silver oxide coatings 
 
After the production and mechanical characterization of PES270A35D6 braided stent (see Chapter 
II), silver and silver oxide coatings were deposited on stents by non-reactive and reactive pulsed dc 
magnetron sputtering, taking in account previously antibacterial results obtained for these coating 
in stainless steel (Chapter III and Chapter IV). In order to remove impurities and avoid 
contamination, stents were previously cleaned ultrasonically, during 1 h, with petroleum ether.  
Ag, AgO10, AgO20 and AgO100 coatings were, once again, deposited by non-reactive and reactive 
magnetron sputtering in PES270A35D6 with the conditions described in section 2.1. of Chapter IV 
and Table 17 in section 3.1 of Chapter IV. Samples of stainless steel were placed along the stents, 
in order to easily characterize the coating, in cytotoxicity assays.  
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2.2. Characterization of silver and silver oxide coatings 
 
The morphology of coated stents with silver and silver oxide, were evaluated by SEM analysis in an 
EDAXNova nano-SEM200 equipment. Three different regions of stents’ surface were analyzed and 
a representative micrograph was taken. Samples were mounted on aluminum bases with carbon 
tape, sputter-coated with gold/palladium before observation.   
In order to evaluate the potential application of stents in human body, cytotoxicity and antibacterial 
tests were performed. Thus, coated stents were sterilized at 121 ⁰C during 15min in autoclave, 
before all the biological assays. The biological assays were realized in Centro de Engenharia 
Biológica at Universidade do Minho. 
Concerning the cytotoxicity evaluation, assays were taken adapting ISO 10993-5 [170] and 
CellTiter 96® AQueous One Solution Cell Proliferation protocol and it was used fibroblast 3T3 cells 
(CCl-163) obtained from American Type Cell Collection [171]. Fibroblast cells were grown in 
Dulbecco Modified Eagle Medium (DMEM) containing 1% of penicillin streptomycin (PS, Gibco) and 
10% of fetal bovine serum (FBS-Gibco) until obtaining 80% of confluence. After detachment of cells, 
50 µl of cell suspension with 1x105 cells.ml-1 were added to each plate of a 96 well’s plate and 
incubated for 24h.  At the same time, coated stainless steel coupons were placed in six well plates 
with 3 ml of DMEM and incubated with 5% of CO2 at 37 ⁰C for 24 h, 48 h, 168 h and 720 h. After 
the pre determinate time, 50 µl of the medium in contact with the coated samples were removed 
for each well and added to 96 well plate with cells, being incubated with 5% of CO2 at 37 ⁰C for 24 
h. After the incubation, 20 µl of MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium) inner salt (Promega CellTiter 96® Aqueous Non-Radioactive Cell 
Prolifaration Assay) was added, in the dark, to each well of the 96 wells plate. The plate was 
incubated with 5% of CO2 at 37 ⁰C for 1 h and after that the absorbance of the resulting solution 
was measured at 490 nm. MTS assay is accurate, fast and reliable method [54,172]. The MTS 
tetrazolium compound is bioreduced by cells into a colored formazan product, through the 
mitochondrial activity of viable cells. This conversion is probably accomplished by NADPH or NADH 
produced by dehydrogenase enzymes in metabolically active cells [171]. 
The number of living cells in culture is directly proportional to the amount of formazan produced 
by  enzymes [54,172]. 
Cellular viability was measured taking in account the ratio of the difference between cell grown in 
control (samples without coating - 100%) and coated samples over the control growth (equation 
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21). Assays were run in triplicate, three different times. Stainless steel was used in cytotoxicity 
tests, once the aim is to test the coating cytotoxicity and using square samples of stainless steel 
there is a major contact area between coating and medium and a less complex geometry, when 
compared to braided stents.  
 
% 𝑐𝑒𝑙𝑙 𝑣𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =
𝑠𝑎𝑚𝑝𝑙𝑒
𝑐𝑜𝑛𝑡𝑟𝑜𝑙
∗ 100 (21) 
 
Regarding antibacterial activity, it was tested against the clinical isolated Staphylococcus 
epidermidis (IE 186) and the assays were realized by the adaptation of Standard Japanese 
Industrial Standard (JIS) Z 2801 [173]. Bacterium was grown in tryptic Soy Agar (TSA, Merck, 
Germany), during 24 h at 37 ⁰C. S. epidermidis was inoculated in tryptic soy broth (TSB, Merck, 
Germany) and incubated for 18 h at 37 ºC under agitation (120 rpm). Subsequently, bacterial 
concentration was adjusted to 1x106 cells.mL-1, via absorbance readings at 640 nm, using the 
correspondent calibration curve. Coated and uncoated (control) PES stents were inserted in falcons 
with 3 ml of cellular suspension and incubated, for 24 h, at 37 ⁰C and a constant agitation of 120 
rpm. After incubation period, stents were transferred for new falcons and 5 ml of a saline solution 
with a non-ionic surfactant was added. Samples were vortexed 5 times for 5 seconds, each, in 
order to detach bacteria from stent’s surface. Serial dilutions were performed and bacteria were 
plated in TSA plates at 37 ⁰C, during 24 h. Thereafter the number of colonies forming unites 
(CFU’s) were counted. All assays were run in triplicate and in three independent times.  
At the same time, some samples were taken out after incubation period and, consequently, biofilm 
formation  was expected, and were dehydrated by an immersion in increasing ethanol 
concentration solutions of 70, 95 and 100% (v/v) for 10, 10 and 20 minutes, respectively, for 
further observation in SEM.  
For statistical analysis, one-way ANOVA analysis was used, by applying Tukey multiple comparisons 
test, using the software GraphPad Prism 6. All tests were performed with a confidence level of 95%. 
Mechanical properties after stent functionalization were evaluated, once stents’ therapeutic efficacy 
is several influenced by their mechanical behavior. Thus, in order to keep, adequately, their 
function, stents should present a good mechanical behavior [174]. Mechanical behavior, including: 
cover factor and porosity, radial and longitudinal compression and bending tests, of coated stents 
were tested and compared with PES stents (previously reported and tested in Chapter II) with the 
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intention of understand and study the influence of silver and silver oxide coatings in mechanical 
performance. In mechanical testes were used samples with 4 cm of length.  
 
3. Results and Discussion 
 
3.1. Coating’s Characterization  
 
In Figure 52 it is possible to observe the PES stent produced (PES270A35D6), as well as PES stent 
coated with silver and silver oxide (Ag and AgO100, respectively). 
 
  
Figure 52-Braided PES stents uncoated, and coated with Ag and AgO100, by the same order. 
 
SEM analysis were performed, with the intention of study coating’s morphology and chemical 
composition. SEM analysis on coated stents, presented in Figure 53, shows a homogenous coating 
in all samples, meaning a successful deposition on a 3D substrate. 
 
 Chapter V- Fibrous Stents with Antibacterial Coatings 
 
117 
 
 
Figure 53- SEM micrographs of uncoated (a) and b)) and coated (c), d), e), f), g), h), i) and j)) polyester stents and a more 
detailed view of surfaces. 
 
Biological Characterization 
 
Firstly, with the purpose to analyze the applicability of the coatings as a biomaterial, silver and 
silver oxide coated stainless steel coupons cytotoxicity was assessed in fibroblast cells, through 
MTS assay, which gives the samples’ toxicity on cells in a precise, fast and reliable way. Cellular 
viability of coatings, over time, can be observed in Figure 54. 
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Figure 54- Rate of fibroblast cell viability, over time, for the different coatings. 
 
Despite the several studies highlighting the toxicity of silver to several cultured cells, at least, Ag 
and AgO100 coatings presented a cellular viability superior to 70%, which is the limit of cytotoxicity 
determined by International Standard ISO 10993-5. Concerning silver oxide coatings, AgO100 
sample is the one with lower silver at. %, which is expected to be the sample with lower cytotoxicity.  
Thus, according to cytotoxicity results, Ag and AgO100 stents are viable to insert in human body 
and being used as a biomaterial. So, for now on, the remained biological and mechanical tests will 
be performed only for these coatings. 
Regarding antibacterial properties, an antibacterial assay were performed in order to evaluate 
antibacterial properties of the coated stents against S. epidermidis that is reported as bacterium 
with propensity to form biofilms [59,175,176]. The results obtained, regarding logarithm of 
bacterial concentration (CFU.ml-1), are presented in Figure 55, as well as, SEM images for 
respectively biofilm’s formation.  
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Figure 55- Logarithm of bacterial concentration after 24h of contact between stents and Staphylococcus epidermidis and SEM 
images of biofilm’s formation. Concentrations that are significantly different (* p<0.05) of each compound compared to control. 
 
From the observation of Figure 55 it is possible to verify that the addition of silver promotes 
significant decrease (p<0.05) in stent’s bacterial adhesion, however, this decrease is not sufficient 
to provide antibacterial properties to silver coated stents, once according to JIS Z 2801 it is 
necessary a logarithmic difference of 2 values between antibacterial products and untreated 
products. On the other hand, the logarithmic difference between PES stents and coated stents with 
silver oxide is 2 values, which means that PES stents coated with silver oxide present antibacterial 
properties. Thus, as expected, the formation of biofilm is higher in uncoated stents and decreases 
with the introduction of silver and silver oxide coatings. 
As already discussed in Chapter III and IV, the antibacterial effect of silver and the exact mechanism 
of actuation is poorly understood. Nonetheless, the antibacterial behavior of silver oxide coated 
stents should be attributed to a higher formation of ROS, which leads to a most effective 
antibacterial behavior due to the toxic character of these species to bacterial cells.  
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In Figure 56 there are present the results of logarithm of bacterial concentration (CFU.ml-1) from 
cellular suspension which was in contact with PES stents coated and uncoated. It is possible to 
observe that bacterial concentration statistical decreases with the incorporation of silver and even 
more with the incorporation of silver oxide (p<0.05), which leads to the conclusion that coated 
stents not only decreases the bacterial adhesion in stents’ surface but even diffuse the silver to the 
medium and, consequently, causing the death of bacteria.  
 
 
 
Figure 56-Logarithm of bacterial concentration in bacterial suspension after 24h of contact between stents and Staphylococcus 
epidermidis. Concentrations that are significantly different (*p<0.05) of each compound compared to control. 
 
Mechanical Behavior 
 
After stents functionalization and characterization, it was necessary to observe not only the 
mechanical behavior of stents but also the coatings behavior during mechanical efforts, ensuring, 
this way that no coating delamination occurs.  
Porosity and cover factor for PES stents and coated PES stents are similar once those parameters 
are calculated through equations 8 and 9, since these parameters are not influenced by a 
nanocoating (thicknesses lower than 160 nm for silver coatings and 195 nm for silver oxide 
coatings), taking in account the dimensions of the stent structure and monofilament thickness (270 
µm).  Stents presented a good percentage of porosity and cover factor, once they showed a porosity 
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of 80% and a consequently cover factor of 20%, which is a good value and allows the stent to 
maintain mechanical performance required, avoiding collapse [41]. Porosity and cover factor 
depends on monofilament’s diameter and mandrel’s diameter, as demonstrated by equation 8 and 
equation 9 (Chapter II). The good results on porosity and cover factor can be attributed to the lower 
diameter of the used monofilaments (270 µm) that cover less area on mandrel surface than higher 
diameters. Furthermore, a high mandrel diameter, as the used one (6 mm) leads to a less 
deposition of yarns on the mandrel and, consequently, a reduction in mandrel’s cover area.   
In Figure 57 it is possible to observe that mechanical behavior of PES and coated stents, regarding 
longitudinal and radial compressions. It is possible to observe that all samples present a linear 
trend during compression, which means that for the required extension stents remained in elastic 
domain, with no permanent alteration in the structure.  However, a different behavior is observed, 
when a comparison is made between the polyester and coated stents. In longitudinal compression, 
it is clear that the material is influencing the mechanical behavior. Thus, with the addition of a 
coating, the stiffness of the material increases, from 0.02 N.mm-1 (PES) to 0.03 N.mm-1 and 0.05 
N.mm-1 (AgO and Ag coated stents, respectively), and, consequently, a higher force is required for 
the same elongation. On the other hand, in radial compression, materials’ type do not play the 
main contribution to the mechanical behavior, but the structure itself. In radial compression, the 
contact area between the stent and the applied force is much higher, and thus, the structure has 
a more important role in this type of compression. For radial compression, Ag coated stent present 
a stiffness of 0.36 N.mm-1 that increase to 0.55 N.mm-1 for PES stent and to 0.90 N.mm-1 for AgO 
coated stent. Furthermore, silver coatings are considered lubricants [153,177]. Thus, and once in 
radial compression the structure has the main contribution, the incorporation of silver coatings can 
lead to a slippage between the monofilaments and, this way, decrease the necessary force to the 
required compression.  
 
 
 Chapter V- Fibrous Stents with Antibacterial Coatings 
 
122 
 
 
Figure 57-Relationship between force and extension for longitudinal (a)) and radial (b)) compression. 
 
Coated stents were observed in SEM before and after mechanical testing, in order to evaluate 
damage in coatings. From the analysis of Figure 58, it is possible to observe differences in 
morphology of silver coated stent, before and after mechanical tests, due to the rearrangement of 
silver columns, once it is a ductile coating, in order to accumulate the tensions to which it is subject. 
No other significant changes, like delamination, are visible in silver and silver oxide coatings, after 
the mechanical tests. These results suggest that these coatings are suitable to stents applications, 
since there is no evidence of delamination of the coating or even loss of adhesion, indicating that 
coatings will support adequately the mechanical forces and since there is no delamination, the 
dangerous of delivering parts of coating for blood current will not occur.  
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Figure 58- SEM micrographs of silver and silver oxide coated stents before (a) and b)) and after (a') and b')) mechanical tests, 
respectively. 
 
Combining all the biological and mechanical tests, polyester stent coated with silver oxide (AgO100) 
seems to be an excellent candidate to be inserted in human body and replace, actual metallic 
stents, with the advantage of providing antibacterial properties.  
 
4. Partial Conclusions 
 
A 100% polyester braided stent (PES270A35D6) was functionalize with Ag and AgxO coatings 
through dc non-reactive and reactive magnetron sputtering, in order to substitute and minimize the 
disadvantages of metallic stents used nowadays.  
Cytotoxicity assays revealed that both Ag and AgO100 are not cytotoxic and can be used in human 
body. 
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Antibacterial tests revealed the antibacterial behavior of AgO100 coating unlike Ag coating, 
probably due to a higher formation of ROS by silver oxide coating.  
Mechanical tests were performed and coated stents morphology before and after tested were 
assessed by SEM and no delamination or poor adhesion were notice.  
Considering all tests performed, polyester coated stent with silver oxide seems to present a great 
potential to be applied as a biomaterial or medical device and be a candidate of substitution of 
nitinol commercial stents, as summarize in Figure 59.  
 
 
Figure 59- Summary of the mechanical and biological behavior of polyester coated stent with silver oxide. 
 
Silver oxide coated stents present a good mechanical behavior, when compared with commercial 
nitinol stents and as an advantage it provides antibacterial properties, without causing any damage 
to human organism.   
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1. Main Conclusions 
 
The main objective of this study was to develop a 100% fibrous stent, with antibacterial properties, 
able to minimize the disadvantages associated to metallic. Thus, primarily, it was necessary to 
study and characterize different fibrous materials (monofilaments) in order to develop fibrous 
braided stents, with different braided parameters. Those stents were subject to mechanical tests, 
and were compared to the stents available in the market. After obtaining a fibrous stent able to 
compete, mechanically, with the metallic ones, fibrous stents were coated, through dc magnetron 
sputtering, with silver and silver oxides with the intuit to achieve antibacterial properties. During 
the deposition process, oxygen content was varied, in order to understand the influence of oxygen 
on physical, chemical and structural properties of coatings and its effect on the antibacterial 
behavior. Finally, coated stents were, again, mechanical tested, and biological properties, as 
antibacterial evaluation, cytotoxicity and biofilm formation, were studied to confirm a possible 
application of the coating in cardiovascular stents. 
 
Along the work, some relevant conclusions were obtained, specifically: 
 
i) Within this work, 100% fibrous stents were developed using braiding technology and the 
influence of different material, process and structural parameters such as fiber type and diameter, 
braiding angle and mandrel diameter on their performance was thoroughly investigated. Regarding 
fiber diameter and braiding angle, it is possible to conclude that the increase in these parameters 
leads to higher radial and longitudinal compression resistance, however, the porosity is reduced. 
On the other hand, the increase in the mandrel diameter improves the porosity but reduce the 
mechanical performance.  
 
ii) According to the experimental results, the best performance (i.e properties closely matched 
with those of commercial metallic stents) was achieved for polyester stents with 270 µm yarn 
diameter, braiding angle of 35⁰ and mandrel diameter of 6 mm, providing the values of radial 
compression, longitudinal compression, porosity and unchanged bending diameter of 1.29 N, 0.23 
N, 80% and 85.5%, respectively. The properties of these 100% fibrous stents are in the range 
offered by commercial metallic stents. 
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iii) Silver and silver oxide thin films were deposited by non-reactive (for Ag thin film) and 
reactive (for AgxO thin films) pulsed dc magnetron sputtering. The structural and morphological 
characterizations revealed that Ag thin film forms a continuous layer, while the incorporation of 
oxygen in the deposition atmosphere lead to the formation of a thin film composed by a mixture of 
two crystalline phases: Ag and silver oxide. The latter thin film was characterized by the presence 
of islands with several hundreds of nanometers surrounded by smaller nanoparticles with tens of 
nanometers. The halo inhibition zone tests revealed the antibacterial behavior of AgxO thin films 
against S. epidermidis and S. aureus; conversely no antibacterial effect was found in Ag thin film. 
The differences between these two coatings might be related not only to the presence of silver 
oxide phase, but also to the differences found in coatings growth mode; with Ag coatings forming 
a continuous layer and AgxO forming islands surrounded by smaller nanoparticles that should 
promote silver ion release (known as antimicrobial agent). Thus, in order to better understand the 
mechanism that rules the antimicrobial activity of the AgxO coatings new depositions were 
performed. 
 
iv) Different AgxO coatings, were deposited with different O2 flow, during the deposition 
process. The structural and morphological characterizations revealed that, Ag coating forms a 
continuous layer, composed by crystalline FCC-Ag phase. The incorporation of oxygen in the 
deposition atmosphere leads to the formation of a coating composed by a mixture of Ag2O+ AgO 
phases. As the amount of oxygen flow increases, the observed continuous thin film became, only, 
AgO, with a monoclinic crystalline phase. Halo inhibition testes revealed the antibacterial behavior 
of AgxO coating unlike Ag coating. By ICP-OES measurements the Ag+ release is similar for the silver 
and silver oxide coatings. So a new mechanism for the observed antimicrobial activity was 
proposed. The incorporation of oxygen leads to a higher formation of ROS and, consequently, to 
an antibacterial behavior. The obtained results suggest that AgxO coating, deposited by dc 
magnetron sputtering has potential to be used in coronary stents. 
 
v) Stents functionalized with silver and silver oxide coatings demonstrated that silver oxide 
stents present antibacterial behavior.  Cytotoxicity assays revealed that both silver and silver oxide 
coated stents are not cytotoxic and can be used in human body. 
 
                                                               Chapter VI- Conclusions 
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Considering all tests performed, polyester coated stent with silver oxide seems to present a great 
potential to be applied as a biomaterial and be a candidate of substitution of nitinol commercial 
stents. Silver oxide coated stents present a good mechanical behavior, when compared with nitinol 
stents available in the market and as an advantage it is provide with antibacterial properties, without 
causing any harm to human body.   
 
2. Future Work 
 
Despite the promised results obtained in this work, and considering the final application, some 
suggestions of future investigation can be proposed.  
 
Thus, it will be necessary to evaluate the mechanical behavior of stent in a simulated body fluid, 
as well as execute fatigue tests in stents, in order to evaluate the performance of the stents over 
the time and the behavior of coatings, when subject to repeated loads. Furthermore, biological 
assays should be realized in order to confirm the major production of ROS species from silver oxide 
coatings, when compared with silver coatings.  
 
Once, medical devices can be colonized by several species, antibacterial assays against other 
species, like Escherichia coli and Pseudomonas aeruginosa should be carried out. Furthermore, 
another coatings should be studied and incorporate in the stent’s surface, like anti-inflammatory 
coatings, with the sense of minimize an inflammatory response from the human body. Additionally, 
studies regarding stent’s sensing should be performed, for non-invasive follow-up of the stent 
location, function and integration in the patient. 
 
Finally, it would be important to develop a stent able to provide mechanical support, and 
antibacterial properties, only while it is needed and then disappear from the vessel, allowing its 
natural healing and avoiding the risks associated with having a permanent implant in place. 
Consequently, bioabsorbable material should be considered for further studies.  
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